Back to
Associate Professor Tanya Applegate

Associate Professor Tanya Applegate

Senior Lecturer
Medicine & Health
The Kirby Institute

Dr Applegate has worked and studied as laboratory research scientist for over 20 years, including within regulatory, hospital, private industry and academic environments. Tanya's PhD specialised in the development of novel molecular diagnostics and her implementation research aims to provide equitable access to health care by improving linkage to care for people who are marginalised or living in remote or resource limited settings.

Tanya is a Senior Lecturer within Surveillance Evaluatio...
Phone
+ 61 2 9385 9958
E-mail
tapplegate@kirby.unsw.edu.au
  • Book Chapters | 2006
    Mokany E; Todd AV; Fuery CJ; Applegate TL, 2006, 'Diagnosis and Monitoring of PML-RARα-Positive Acute Promyelocytic Leukemia by Quantitative RT-PCR', in Myeloid Leukemia, Springer Nature, pp. 127 - 147, http://dx.doi.org/10.1385/1-59745-017-0:127
  • Journal articles | 2025
    Chandra S; Broom A; Ridge D; Peterie M; Lafferty L; Broom J; Kenny K; Treloar C; Applegate T, 2025, 'Treatment ‘cultures’, sexually transmitted infections and the rise of antimicrobial resistance', Sociology of Health and Illness, 47, http://dx.doi.org/10.1111/1467-9566.13832
    Journal articles | 2024
    Applegate TL; Causer LM; Gow I; Alternetti N; Anderson L; Borgnolo B; Cooney L; Cunningham P; Fernando M; Hengel B; Huang RL; Kayago K; King JM; Lew HJ; Martinello M; Milic M; Miller K; O’Connor S; Patel P; Phillips E; Rawlinson W; Sharma A; Shephard MDS; Tangey A; Smith K; Williams AL; Andrewartha K; Guy R; Matthews SJ, 2024, 'Paving the way for quality assured, decentralised point-of-care testing for infectious disease in primary care - Real world lessons from remote Australia', Expert Review of Molecular Diagnostics, http://dx.doi.org/10.1080/14737159.2024.2403091
    Journal articles | 2024
    Bertagnolio S; Dobreva Z; Centner CM; Olaru ID; Donà D; Burzo S; Huttner BD; Chaillon A; Gebreselassie N; Wi T; Hasso-Agopsowicz M; Allegranzi B; Sati H; Ivanovska V; Kothari KU; Balkhy HH; Cassini A; Hamers RL; Weezenbeek KV; Aanensen D; Alanio A; Alastruey-Izquierdo A; Alemayehu T; Al-Hasan M; Allegaert K; Al-Maani AS; Al-Salman J; Alshukairi AN; Amir A; Applegate T; Araj GF; Villalobos MA; Årdal C; Ashiru-Oredope D; Ashley EA; Babin FX; Bachmann LH; Bachmann T; Baker KS; Balasegaram M; Bamford C; Baquero F; Barcelona LI; Bassat Q; Bassetti M; Basu S; Beardsley J; Vásquez GB; Berkley JA; Bhatnagar AK; Bielicki J; Bines J; Bongomin F; Bonomo RA; Bradley JS; Bradshaw C; Brett A; Brink A; Brown C; Brown J; Buising K; Carson C; Carvalho AC; Castagnola E; Cavaleri M; Cecchini M; Chabala C; Chaisson RE; Chakrabarti A; Chandler C; Chandy SJ; Charani E; Chen L; Chiara F; Chowdhary A; Chua A; Chuki P; Chun DR; Churchyard G; Cirillo D; Clack L; Coffin SE; Cohn J; Cole M; Conly J; Cooper B; Corso A; Cosgrove SE; Cox H; Daley CL; Darboe S; Darton T; Davies G; de Egea V; Dedeić-Ljubović A; Deeves M; Denkinger C; Dillon JAR; Dramowski A; Eley B, 2024, 'WHO global research priorities for antimicrobial resistance in human health', The Lancet Microbe, 5, http://dx.doi.org/10.1016/S2666-5247(24)00134-4
    Journal articles | 2024
    Bonello M; Applegate TL; Badman S; Bradshaw CS; Broom A; Field P; Hocking JS; Huston WM; Kong F; Murray GL; Mokany E; Pasricha S; Todd AV; Whiley DM; Wiseman V; Guy R, 2024, 'The AMR Hub: a public–private partnership to overcome barriers to commercialisation and deliver antimicrobial stewardship innovations', Microbiology Australia, 45, pp. 48 - 53, http://dx.doi.org/10.1071/MA24017
    Journal articles | 2024
    Chandra S; Broom A; Peterie M; Ridge D; Kenny K; Lafferty L; Treloar C; Applegate T; Broom J, 2024, 'Emerging Dilemmas in the Age of Resistance: The Case of Sexually Transmitted Infections', QUALITATIVE HEALTH RESEARCH, http://dx.doi.org/10.1177/10497323241302668
    Journal articles | 2024
    Grebely J; Matthews S; Causer LM; Feld JJ; Cunningham P; Dore GJ; Applegate TL, 2024, 'We have reached single-visit testing, diagnosis, and treatment for hepatitis C infection, now what?', Expert Review of Molecular Diagnostics, 24, pp. 177 - 191, http://dx.doi.org/10.1080/14737159.2023.2292645
    Journal articles | 2024
    Lafferty L; Applegate TL; Lewis S; Drysdale K; Monaghan R; Kelly-Hanku A; Guy R; Treloar C, 2024, 'Pre-market health systems barriers and enablers to infectious diseases point-of-care diagnostics in Australia: qualitative interviews with key informants', BMC Infectious Diseases, 24, http://dx.doi.org/10.1186/s12879-024-10214-5
    Journal articles | 2024
    Matthews SJ; Miller K; Andrewartha K; Milic M; Byers D; Santosa P; Kaufer A; Smith K; Causer LM; Hengel B; Gow I; Applegate T; Rawlinson WD; Guy R; Shephard M, 2024, 'External Quality Assessment (EQA) for SARS-CoV-2 RNA Point-of-Care Testing in Primary Healthcare Services: Analytical Performance over Seven EQA Cycles', Diagnostics, 14, http://dx.doi.org/10.3390/diagnostics14111106
    Journal articles | 2024
    Pérez Chacón G; Saha A; Phillips E; Guy R; Applegate TL; Causer L; Mcgregor S; Hengel B, 2024, 'Syphilis point-of-care tests: an Australian perspective', Microbiology Australia, 45, pp. 127 - 131, http://dx.doi.org/10.1071/MA24036
    Journal articles | 2024
    Sacks-Davis R; van Santen DK; Boyd A; Young J; Stewart A; Doyle JS; Rauch A; Mugglin C; Klein M; van der Valk M; Smit C; Jarrin I; Berenguer J; Lacombe K; Requena MB; Wittkop L; Leleux O; Bonnet F; Salmon D; Matthews GV; Guy R; Martin NK; Spelman T; Prins M; Stoove M; Hellard M; Ke T; Zhang Y; Pedrana A; Asselin J; Dawe J; Wilkinson A; Schinkel J; Sogni P; Esterle L; Gilbert C; Merchadou L; Gillet S; Khan C; Le Marec F; Perrier A; Matthews G; Shaw I; Martinello M; Applegate T; Carson J; Harney B; Bryant M; Jarrin Vera I; Alejos B; Lazarus JV; Moreno C; Izquierdo R; Rava M; Wang S; Lumia J; Pexos C; Peiris H; Saeed S; Moodie E; Pick N; Conway B; Hull M; Wong A; Gill J; Barrett L; Cohen J; Cox J; Cote P; Haider S; Rouleau D; Vachon ML; Rachlis A; Sandre R; Walmsley S; Sadr A; Cooper C; Sanche S; Salazar-Viscaya L; Kusejko K; Hage K; Requena MB; Girard PM; Brucker M; Vincensini JP, 2024, 'Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010–19: an analysis of data from a consortium of prospective cohort studies', The Lancet HIV, 11, pp. e106 - e116, http://dx.doi.org/10.1016/S2352-3018(23)00267-9
    Journal articles | 2024
    Wong A; Applegate T; Boettiger DC; Varma R; Guy R; Medland N, 2024, 'Unnecessary antibiotic use in men who have sex with men (MSM) with anogenital symptoms attending a sexual health clinic: a retrospective analysis', Sexually Transmitted Infections, 100, pp. 435 - 441, http://dx.doi.org/10.1136/sextrans-2024-056120
    Journal articles | 2024
    Wong A; Lima N; Applegate TL; Guy R; Huston WM; Hocking JS; Boettiger D, 2024, 'Viability of Chlamydia trachomatis in Different Anatomical Sites-a Systematic Review and Meta-analysis', CLINICAL INFECTIOUS DISEASES, http://dx.doi.org/10.1093/cid/ciae401
    Journal articles | 2024
    Wu H-J; Applegate TL; Kwon JA; Cunningham EB; Grebely J; Gray RT; Shih STF, 2024, 'The cost-effectiveness of integrating simplified HCV testing into HIV pre-exposure prophylaxis (PrEP) and treatment services among men who have sex with men in Taiwan', The Lancet regional health. Western Pacific, 48
    Journal articles | 2024
    Wu HJ; Applegate TL; Kwon JA; Cunningham EB; Grebely J; Gray RT; Shih STF, 2024, 'The cost-effectiveness of integrating simplified HCV testing into HIV pre-exposure prophylaxis (PrEP) and treatment services among men who have sex with men in Taiwan', The Lancet Regional Health - Western Pacific, 48, http://dx.doi.org/10.1016/j.lanwpc.2024.101119
    Journal articles | 2024
    Wu HJ; Shih STF; Applegate TL; Kwon JA; Cunningham EB; Grebely J; Gray RT, 2024, 'Impact of simplified HCV diagnostic strategies on the HCV epidemic among men who have sex with men in the era of HIV oral pre-exposure prophylaxis in Taiwan: a modelling study', Journal of the International AIDS Society, 27, http://dx.doi.org/10.1002/jia2.26251
    Journal articles | 2023
    Broom A; Peterie M; Kenny K; Broom J; Kelly-Hanku A; Lafferty L; Treloar C; Applegate T, 2023, 'Vulnerability and antimicrobial resistance', Critical Public Health, 33, pp. 308 - 317, http://dx.doi.org/10.1080/09581596.2022.2123733
    Journal articles | 2023
    Broom A; Peterie M; Ridge D; Lafferty L; Kenny K; Broom J; Kelly-Hanku A; Treloar C; Applegate T, 2023, 'Sex, drugs and superbugs: The rise of drug resistant STIs', SSM - Qualitative Research in Health, 4, http://dx.doi.org/10.1016/j.ssmqr.2023.100310
    Journal articles | 2023
    Grebely J; Markus C; Causer LM; Silk D; Comben S; Lloyd AR; Martinez M; Cunningham EB; O'Flynn M; Dore GJ; Matthews S, 2023, 'A national programme to scale-up decentralised hepatitis C point-of-care testing and treatment in Australia', The Lancet Gastroenterology and Hepatology, 8, pp. 204 - 207, http://dx.doi.org/10.1016/S2468-1253(22)00355-7
    Journal articles | 2023
    Koopsen J; Matthews G; Rockstroh J; Applegate TL; Bhagani S; Rauch A; Grebely J; Sacks-Davis R; Ingiliz P; Boesecke C; Rebers S; Feld J; Bruneau J; Martinello M; Hellard M; Dore GJ; Schinkel J; van der Valk M; Adams T; Amjad S; Appelhans C; Becker B; Bouchard R; Braun D; Bruelisauer C; Calcagnile S; Carroll A; Cerocchi O; Chronister K; Cordes C; Dore G; Evans F; Fedele S; Ferguson C; Fraser C; Ganase B; Gane E; George V; Gerlach C; Gilleece Y; Gilliver R; Grube C; Gustafson J; Haas A; Hagenauer M; Harris M; Helder J; Hirter D; Hull M; Katz S; Kim A; Kotsoros B; Lacalamita M; Lindergard G; Lutz T; Macabodbod L; Manz M; Marks P; Messina P; Mohrmann K; Monnich C; Moon J; Moriggia A; Morris G; Morrish T; Nelson M; Oliver V; Patterson J; Peters M; Petoumenos K; Porretta H; Raymode P; Read P; Reece S; Saidi A; Sasadeusz J; Scherler P; Schröder R; Selfridge M; Sevehon A; Shaw D; Sulkowski M; Tamaddoni M; Thunder O; Thurnheer MC; Tu E; Ustianowski A; Witele E, 2023, 'Hepatitis C virus transmission between eight high-income countries among men who have sex with men: a whole-genome analysis', The Lancet Microbe, 4, pp. e622 - e631, http://dx.doi.org/10.1016/S2666-5247(23)00108-8
    Journal articles | 2023
    Martinello M; Carson JM; Van Der Valk M; Rockstroh JK; Ingiliz P; Hellard M; Nelson M; Lutz T; Bhagani S; Kim AY; Hull M; Cordes C; Moon J; Feld JJ; Gane E; Rauch A; Bruneau J; Tu E; Applegate T; Grebely J; Dore GJ; Matthews GV, 2023, 'Reinfection incidence and risk among people treated for recent hepatitis C virus infection', AIDS, 37, pp. 1883 - 1890, http://dx.doi.org/10.1097/QAD.0000000000003651
    Journal articles | 2023
    Nyein PP; Tillakeratne S; Phyu S; Yee MM; Lwin MM; Htike KL; Aung MT; Grebely J; Applegate T; Hanson J; Matthews G; Lin KS, 2023, 'Evaluation of Simplified HCV Diagnostics in HIV/HCV Co-Infected Patients in Myanmar', Viruses, 15, pp. 521, http://dx.doi.org/10.3390/v15020521
    Journal articles | 2023
    Zhang Y; Holt M; Chan C; Applegate TL; Bavinton BR; Broady TR; Keen P; Wulandari LPL; Mao L; McManus H; Medland NA; Prestage G; Wiseman V; Guy RJ, 2023, 'National Surveillance of Home-Based HIV Testing Among Australian Gay and Bisexual Men, 2018–2020: Uptake After Commercial Availability of HIV Self-Tests', AIDS and Behavior, 27, pp. 4106 - 4113, http://dx.doi.org/10.1007/s10461-023-04124-x
    Journal articles | 2022
    Bartlett SR; Verich A; Carson J; Hosseini-Hooshyar S; Read P; Baker D; Post JJ; Finlayson R; Bloch M; Doyle JS; Shaw D; Hellard M; Martinez M; Marks P; Dore GJ; Matthews GV; Applegate T; Martinello M; Hosseini Hooshyar S, 2022, 'Patterns and correlates of hepatitis C virus phylogenetic clustering among people living with HIV in Australia in the direct-acting antiviral era: A molecular epidemiology study among participants in the CEASE cohort', Health Science Reports, 5, http://dx.doi.org/10.1002/hsr2.719
    Journal articles | 2022
    Catlett B; Hajarizadeh B; Cunningham E; Wolfson-Stofko B; Wheeler A; Khandaker-Hussain B; Feld JJ; Martró E; Chevaliez S; Pawlotsky JM; Bharat C; Cunningham PH; Dore GJ; Applegate T; Grebely J, 2022, 'Diagnostic Accuracy of Assays Using Point-of-Care Testing or Dried Blood Spot Samples for the Determination of Hepatitis C Virus RNA: A Systematic Review', Journal of Infectious Diseases, 226, pp. 1005 - 1021, http://dx.doi.org/10.1093/infdis/jiac049
    Journal articles | 2022
    Howe AYM; Rodrigo C; Cunningham EB; Douglas MW; Dietz J; Grebely J; Popping S; Sfalcin JA; Parczewski M; Sarrazin C; de Salazar A; Fuentes A; Sayan M; Quer J; Kjellin M; Kileng H; Mor O; Lennerstrand J; Fourati S; Di Maio VC; Chulanov V; Pawlotsky JM; Harrigan PR; Ceccherini-Silberstein F; Garcia F; Martinello M; Matthews G; Fernando FF; Esteban JI; Müllhaupt B; Wiesch JSZ; Buggisch P; Neumann-Haefelin C; Berg T; Berg CP; Schattenberg JM; Moreno C; Stauber R; Lloyd A; Dore G; Applegate T; Ignacio J; Garcia-Cehic D; Gregori J; Rodriguez-Frias F; Rando A; Gozlan Y; Angelico M; Andreoni M; Babudieri S; Bertoli A; Cento V; Coppola N; Craxì A; Paolucci S; Parruti G; Pasquazzi C; Perno CF; Teti E; Vironet C; Lannergård A; Duberg AS; Aleman S; Gutteberg T; Soulier A; Gourgeon A; Chevaliez S; Pol S; Carrat F; Salmon D; Kaiser R; Knopes E; Gomes P; de Kneght R; Rijnders B; Poljak M; Lunar M; Usubillaga R; Seguin_Devaux C; Tay E; Wilson C; Wang DS; George J; Kok J; Pérez AB; Chueca N; García-Deltoro M; Martínez-Sapiña AM; Lara-Pérez MM; García-Bujalance S; Aldámiz-Echevarría T; Vera-Méndez FJ; Pineda JA; Casado M; Pascasio JM; Salmerón J; Alados-Arboledas JC; Poyato A; Téllez F; Rivero-Juárez A, 2022, 'Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals', JHEP Reports, 4, pp. 100462, http://dx.doi.org/10.1016/j.jhepr.2022.100462
    Journal articles | 2022
    Zhang Y; Guy R; Camara H; Applegate TL; Wiseman V; Treloar C; Lafferty L, 2022, 'Barriers and facilitators to HIV and syphilis rapid diagnostic testing in antenatal care settings in low-income and middle-income countries: A systematic review', BMJ Global Health, 7, pp. e009408, http://dx.doi.org/10.1136/bmjgh-2022-009408
    Journal articles | 2022
    Zhang Y; Wiseman V; Applegate TL; De Abreu Lourenco R; Street DJ; Smith K; Jamil MS; Terris-Prestholt F; Fairley C; McNulty A; Hynes A; Johnson K; Chow E; Bavinton BR; Grulich AE; Stoove M; Holt M; Kaldor JM; Guy RJ; Ong J, 2022, 'Preferences for HIV testing services and HIV self-testing distribution among migrant gay, bisexual and other men who have sex with men in Australia', Frontiers in Medicine, 9, pp. 839479 - 839479, http://dx.doi.org/10.3389/fmed.2022.839479
    Journal articles | 2022
    al Adawiyah R; Boettiger D; Applegate TL; Probandari A; Marthias T; Guy R; Wiseman V, 2022, 'Supply-side readiness to deliver HIV testing and treatment services in Indonesia: Going the last mile to eliminate mother-to-child transmission of HIV', PLOS Global Public Health, 2, http://dx.doi.org/10.1371/journal.pgph.0000845
    Journal articles | 2021
    Abid A; Uddin M; Muhammad T; Awan S; Applegate T; Dore GJ; Cloherty G; Hamid S, 2021, 'Evaluation of hepatitis C virus core antigen assay in a resource-limited setting in Pakistan', Diagnostics, 11, http://dx.doi.org/10.3390/diagnostics11081354
    Journal articles | 2021
    Adawiyah RA; Saweri OPM; Boettiger DC; Applegate TL; Probandari A; Guy R; Guinness L; Wiseman V, 2021, 'The costs of scaling up HIV and syphilis testing in low-and middle-income countries: A systematic review', Health Policy and Planning, 36, pp. 939 - 954, http://dx.doi.org/10.1093/heapol/czab030
    Journal articles | 2021
    Applegate T; Bajis S; Catlett B; Cunningham P; Dore G; Grebely J; Hajarizadeh B, 2021, 'Evaluation of the Aptima HCV Quant Dx Assay for Hepatitis C Virus RNA Detection from Fingerstick Capillary Dried Blood Spot and Venepuncture-Collected Samples', Journal of Infectious Diseases, http://dx.doi.org/10.1093/infdis/jiaa442
    Journal articles | 2021
    Catlett B; Bajis S; Starr M; Dore GJ; Hajarizadeh B; Cunningham PH; Applegate TL; Grebely J, 2021, 'Evaluation of the Aptima HCV Quant Dx Assay for Hepatitis C Virus RNA Detection from Fingerstick Capillary Dried Blood Spot and Venepuncture-Collected Samples', Journal of Infectious Diseases, 223, pp. 818 - 826, http://dx.doi.org/10.1093/infdis/jiaa442
    Journal articles | 2021
    Cunningham EB; Hajarizadeh B; Amin J; Hellard M; Bruneau J; Feld JJ; Cooper C; Powis J; Litwin AH; Marks P; Dalgard O; Conway B; Moriggia A; Stedman C; Read P; Bruggmann P; Lacombe K; Dunlop A; Applegate TL; Matthews GV; Fraser C; Dore GJ; Grebely J, 2021, 'Reinfection Following Successful Direct-acting Antiviral Therapy for Hepatitis C Virus Infection among People Who Inject Drugs', Clinical Infectious Diseases, 72, pp. 1392 - 1400, http://dx.doi.org/10.1093/cid/ciaa253
    Journal articles | 2021
    Hengel B; Causer L; Matthews S; Smith K; Andrewartha K; Badman S; Spaeth B; Tangey A; Cunningham P; Saha A; Phillips E; Ward J; Watts C; King J; Applegate T; Shephard M; Guy R, 2021, 'A decentralised point-of-care testing model to address inequities in the COVID-19 response', The Lancet Infectious Diseases, 21, pp. e183 - e190, http://dx.doi.org/10.1016/S1473-3099(20)30859-8
    Journal articles | 2021
    Matthews GV; Bhagani S; Van der Valk M; Rockstroh J; Feld JJ; Rauch A; Thurnheer C; Bruneau J; Kim A; Hellard M; Shaw D; Gane E; Nelson M; Ingiliz P; Applegate TL; Grebely J; Marks P; Martinello M; Petoumenos K; Dore GJ; Marks P; Feld J; Amjad S; Tu E; Tamaddoni M; Thurnheer MC; Gilleece Y; Fraser C; Moriggia A; Lutz T; Moon J; Read P; Ustianowski A; Cordes C; Sasadeusz J; Hull M; Braun D, 2021, 'Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infection', Journal of Hepatology, 75, pp. 829 - 839, http://dx.doi.org/10.1016/j.jhep.2021.04.056
    Journal articles | 2021
    Zhang Y; Guy RJ; Smith KS; Jamil MS; Prestage G; Applegate TL; Conway DP; Holt M; Keen P; Bavinton B; McNulty AM; Batrouney C; Russell D; Vaughan M; Chen M; Fairley CK; Grulich AE; Kaldor JM; Callander D, 2021, 'Sustaining success: a qualitative study of gay and bisexual men’s experiences and perceptions of HIV self-testing in a randomized controlled trial', BMC Public Health, 21, pp. 2048, http://dx.doi.org/10.1186/s12889-021-12011-0
    Journal articles | 2021
    Zhang Y; Jamil MS; Smith KS; Applegate TL; Prestage G; Holt M; Keen P; Bavinton BR; Chen M; Conway DP; Wand H; McNulty AM; Russell D; Vaughan M; Batrouney C; Wiseman V; Fairley CK; Grulich AE; Law M; Kaldor JM; Guy RJ; Law M, 2021, 'The longer-term effects of access to HIV self-tests on HIV testing frequency in high-risk gay and bisexual men: follow-up data from a randomised controlled trial', The Lancet Regional Health - Western Pacific, 14, pp. 100214 - 100214, http://dx.doi.org/10.1016/j.lanwpc.2021.100214
    Journal articles | 2020
    Bajis S; Applegate TL; Grebely J; Matthews GV; Dore GJ, 2020, 'Novel hepatitic C virus (HCV) diagnosis and treatment delivery systems: Facilitating HCV elimination by thinking outside the clinic', Journal of Infectious Diseases, 222, pp. S758 - S772, http://dx.doi.org/10.1093/infdis/jiaa366
    Journal articles | 2020
    Bajis S; Grebely J; Hajarizadeh B; Applegate T; Marshall AD; Ellen Harrod M; Byrne J; Bath N; Read P; Edwards M; Gorton C; Hayllar J; Cock V; Peterson S; Thomson C; Weltman M; Jefferies M; Wood W; Haber P; Ezard N; Martinello M; Maher L; Dore GJ; Peolim L; How-Chow D; Telenta J; Harvey P; Jones S; Dunlop A; Treloar C; Samuel Y; Poeder F; Crawford S; Baxter A; Keats J; Mowat Y; Silk D; Micallef M; Tamaddoni M; Marks P; Lamoury F; Jayasinghe I; Reid H; Cunningham EB; Bartlett S; Jacka B; Erratt A; Jauncey M; Collie P; Lam T; Gilliver R; Hazelwood S; Houlihan N; Burns C; Lewis R; Morris D; Donohue K; Carthew A; Horasak N; Cherry R; Shin S; Peterson D; Sellwood T; McKeown W; Pritchard-Jones J; Smyth F; Adey S; Clark K; Grebely J; Hajarizadeh B; Edwards M, 2020, 'Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: The LiveRLife study', Journal of Viral Hepatitis, 27, pp. 281 - 293, http://dx.doi.org/10.1111/jvh.13233
    Journal articles | 2020
    Douglas MW; Tay ESE; Wang DS; Ong ATL; Wilson C; Phu A; Kok J; Dwyer DE; Bull RA; Lloyd AR; Applegate TL; Dore GJ; Howe AY; Harrigan R; George J, 2020, 'Impact of an Open Access Nationwide Treatment Model on Hepatitis C Virus Antiviral Drug Resistance', Hepatology Communications, 4, pp. 904 - 915, http://dx.doi.org/10.1002/hep4.1496
    Journal articles | 2020
    Gorstein E; Martinello M; Churkin A; Dasgupta S; Walsh K; Applegate TL; Yardeni D; Etzion O; Uprichard SL; Barash D; Cotler SJ; Matthews GV; Dahari H, 2020, 'Modeling based response guided therapy in subjects with recent hepatitis C infection', Antiviral Research, 180, http://dx.doi.org/10.1016/j.antiviral.2020.104862
    Journal articles | 2020
    Grebely J; Catlett B; Catlett B; Jayasinghe I; Valerio H; Hajarizadeh B; Verich A; Cunningham P; Martinello M; Tillakeratne S; Silk D; Dore GJ; Applegate TL, 2020, 'Time to Detection of Hepatitis C Virus Infection with the Xpert HCV Viral Load Fingerstick Point-of-Care Assay: Facilitating a More Rapid Time to Diagnosis', Journal of Infectious Diseases, 221, pp. 2043 - 2049, http://dx.doi.org/10.1093/infdis/jiaa037
    Journal articles | 2020
    Grebely J; Read P; Cunningham EB; Weltman M; Matthews GV; Dunlop A; Montebello M; Martinello M; Gilliver R; Marks P; Applegate TL; Dore GJ, 2020, 'Elbasvir and grazoprevir for hepatitis C virus genotype 1 infection in people with recent injecting drug use (DARLO-C): An open-label, single-arm, phase 4, multicentre trial', Health Science Reports, 3, http://dx.doi.org/10.1002/hsr2.151
    Journal articles | 2020
    Martinello M; Yee J; Bartlett SR; Read P; Baker D; Post JJ; Finlayson R; Bloch M; Doyle J; Shaw D; Hellard M; Petoumenos K; Lin L; Marks P; Applegate T; Dore GJ; Matthews GV, 2020, 'Moving towards Hepatitis C microelimination among people living with human immunodeficiency virus in Australia: The CEASE study', Clinical Infectious Diseases, 71, pp. 1502 - 1510, http://dx.doi.org/10.1093/cid/ciz985
    Journal articles | 2020
    Van Bockel D; Munier CML; Turville S; Badman SG; Walker G; Stella AO; Aggarwal A; Yeang M; Condylios A; Kelleher AD; Applegate TL; Vallely A; Whiley D; Rawlinson W; Cunningham P; Kaldor J; Guy R, 2020, 'Evaluation of commercially available viral transport medium (VTM) for SARS-CoV-2 inactivation and use in point-of-care (POC) testing', Viruses, 12, pp. 1208, http://dx.doi.org/10.3390/v12111208
    Journal articles | 2019
    Abayasingam A; Leung P; Eltahla A; Bull RA; Luciani F; Grebely J; Dore GJ; Applegate T; Page K; Bruneau J; Cox AL; Kim AY; Schinkel J; Shoukry NH; Lauer GM; Maher L; Hellard M; Prins M; Lloyd A; Rodrigo C, 2019, 'Genomic characterization of hepatitis C virus transmitted founder variants with deep sequencing', Infection, Genetics and Evolution, 71, pp. 36 - 41, http://dx.doi.org/10.1016/j.meegid.2019.02.032
    Journal articles | 2019
    Bajis S; Grebely J; Cooper L; Smith J; Owen G; Chudleigh A; Hajarizadeh B; Martinello M; Adey S; Read P; Gilliver R; Applegate T; Treloar C; Maher L; Dore GJ, 2019, 'Hepatitis C virus testing, liver disease assessment and direct-acting antiviral treatment uptake and outcomes in a service for people who are homeless in Sydney, Australia: The LiveRLife homelessness study', Journal of Viral Hepatitis, 26, pp. 969 - 979, http://dx.doi.org/10.1111/jvh.13112
    Journal articles | 2019
    Bartlett SR; Applegate TL; Jacka BP; Martinello M; Lamoury FMJ; Danta M; Bradshaw D; Shaw D; Lloyd AR; Hellard M; Dore GJ; Matthews GV; Grebely J, 2019, 'A latent class approach to identify multi-risk profiles associated with phylogenetic clustering of recent hepatitis C virus infection in Australia and New Zealand from 2004 to 2015', Journal of the International AIDS Society, 22, pp. e25222, http://dx.doi.org/10.1002/jia2.25222
    Journal articles | 2019
    Catlett B; Carrera A; Starr M; Applegate TL; Lowe P; Philip Cunningham H; Grebely J, 2019, 'Performance evaluation of the Hologic Aptima HCV Quant Dx assay for detection of HCV RNA from dried blood spots', Journal of Clinical Virology, 112, pp. 40 - 44, http://dx.doi.org/10.1016/j.jcv.2019.01.010
    Journal articles | 2019
    Catlett B; Lamoury FMJ; Bajis S; Hajarizadeh B; Martinez D; Mowat Y; Cunningham PH; Jacka BP; Cloherty GA; Marks P; Dore GJ; Grebely J; Applegate TL, 2019, 'Evaluation of a hepatitis C virus core antigen assay from venepuncture and dried blood spot collected samples: A cohort study', Journal of Viral Hepatitis, 26, pp. 1423 - 1430, http://dx.doi.org/10.1111/jvh.13196
    Journal articles | 2019
    Cooke GS; Andrieux-Meyer I; Applegate TL; Atun R; Burry JR; Cheinquer H; Dusheiko G; Feld JJ; Gore C; Griswold MG; Hamid S; Hellard ME; Hou JL; Howell J; Jia J; Kravchenko N; Lazarus JV; Lemoine M; Lesi OA; Maistat L; McMahon BJ; Razavi H; Roberts TR; Simmons B; Sonderup MW; Spearman CW; Taylor BE; Thomas DL; Waked I; Ward JW; Wiktor SZ; Abdo A; Aggarwal R; Aghemo A; Al-Judaibi B; Al Mahtab M; Altaf A; Ameen Z; Asselah T; Baatarkkhuu O; Barber E; Barnes E; Boulet P; Burrows L; Butsashvili M; Chan E; Chow C; Cowie B; Cunningham C; de Araujo A; Diap G; Dore G; Doyle J; Elsayed M; Fajardo E; Gane E; Getehun A; Goldberg D; Got T; Hickman M; Hill A; Hutchinson S; Jones C; Kamili S; Khan A; Lee A; Lee TY; Malani J; Morris TM; Nayagam S; Njouom R; Ocama P; Pedrana A; Peeling R; Reddy A; Sacks J; Sarin S; Shimakawa Y; Silva M; Skala P; Taylor-Robinson S; Thompson A; Thursz M; Tonganibeia A; Wallace J; Ward J; Wolff F; Vickerman P; Yau J, 2019, 'Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission', The Lancet Gastroenterology and Hepatology, 4, pp. 135 - 184, http://dx.doi.org/10.1016/S2468-1253(18)30270-X
    Journal articles | 2019
    Cooke GS; Andrieux-Meyer I; Applegate TL, 2019, 'Hepatology Commissioners. Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission. (vol 4, pg 135, 2019)', LANCET GASTROENTEROLOGY & HEPATOLOGY, 4, pp. E4 - E4, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000463786300001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2019
    Grebely J; Cunningham EB; Dalgard O; Hajarizadeh B; Conway B; Powis J; Bruneau J; Feld J; Read P; Cooper C; Amin J; Bruggmann P; Lacombe K; Stedman C; Hellard M; Marks P; Dunlop A; Moriggia A; Applegate T; Litwin A; Matthews G; Dore G, 2019, 'SAT-232-Reinfection following successful HCV DAA therapy among people with recent injecting drug use', Journal of Hepatology, 70, pp. e732 - e733, http://dx.doi.org/10.1016/s0618-8278(19)31465-3
    Journal articles | 2019
    Hooshyar SH; Martinello M; Yee J; Bartlett S; Read P; Baker D; Post J; Finlayson R; Bloch M; Doyle J; Shaw D; Hellard M; Petoumenos K; Marks P; Applegate T; Dore G; Matthews G, 2019, 'SAT-235-Low HCV reinfection incidence following DAA treatment scale-up in people living with HIV in Australia', Journal of Hepatology, 70, pp. e734 - e734, http://dx.doi.org/10.1016/s0618-8278(19)31468-9
    Journal articles | 2019
    Martinello M; Orkin C; Cooke G; Bhagani S; Gane E; Kulasegaram R; Shaw D; Tu E; Filep E; Petoumenos K; Marks P; Applegate T; Grebely J; Dore G; Nelson M; Matthews G, 2019, 'Shortened duration pan-genotypic therapy with glecaprevir-pibrentasvir for six weeks among people with acute and recent HCV infection', JOURNAL OF HEPATOLOGY, 70, pp. E231 - E231, http://dx.doi.org/10.1016/S0618-8278(19)30432-3
    Journal articles | 2019
    Olmstead AD; Montoya V; Chui CK; Dong W; Joy JB; Tai V; Poon AFY; Nguyen T; Brumme CJ; Martinello M; Matthews GV; Richard Harrigan P; Dore GJ; Applegate TL; Grebely J; Howe AYM, 2019, 'A systematic, deep sequencing-based methodology for identification of mixed-genotype hepatitis C virus infections', Infection, Genetics and Evolution, 69, pp. 76 - 84, http://dx.doi.org/10.1016/j.meegid.2019.01.016
    Journal articles | 2019
    Rodrigo C; Leung P; Lloyd AR; Bull RA; Luciani F; Grebely J; Dore GJ; Applegate T; Page K; Bruneau J; Cox AL; Osburn W; Kim AY; Shoukry NH; Lauer GM; Maher L; Schinkel J; Prins M; Hellard M; Eltahla AA, 2019, 'Genomic variability of within-host hepatitis C variants in acute infection', Journal of Viral Hepatitis, 26, pp. 476 - 484, http://dx.doi.org/10.1111/jvh.13051
    Journal articles | 2018
    Applegate TL; Fajardo E; Sacks JA, 2018, 'Hepatitis C Virus Diagnosis and the Holy Grail', Infectious Disease Clinics of North America, 32, pp. 425 - 445, http://dx.doi.org/10.1016/j.idc.2018.02.010
    Journal articles | 2018
    Bajis S; Maher L; Treloar C; Hajarizadeh B; Lamoury FMJ; Mowat Y; Schulz M; Marshall AD; Cunningham EB; Cock V; Ezard N; Gorton C; Hayllar J; Smith J; Whelan M; Martinello M; Applegate TL; Dore GJ; Grebely J, 2018, 'Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia', International Journal of Drug Policy, 61, pp. 23 - 30, http://dx.doi.org/10.1016/j.drugpo.2018.08.011
    Journal articles | 2018
    Cunningham EB; Amin J; Feld JJ; Bruneau J; Dalgard O; Powis J; Hellard M; Cooper C; Read P; Conway B; Dunlop AJ; Norton B; Litwin AH; Hajarizadeh B; Thurnheer MC; Dillon JF; Weltman M; Shaw D; Bruggmann P; Gane E; Fraser C; Marks P; Applegate TL; Quiene S; Siriragavan S; Matthews GV; Dore GJ; Grebely J, 2018, 'Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study', International Journal of Drug Policy, 62, pp. 14 - 23, http://dx.doi.org/10.1016/j.drugpo.2018.08.013
    Journal articles | 2018
    Grebely J; Conway B; Cunningham EB; Fraser C; Moriggia A; Gane E; Stedman C; Cooper C; Castro E; Schmid P; Petoumenos K; Hajarizadeh B; Marks P; Erratt A; Dalgard O; Lacombe K; Feld JJ; Bruneau J; Daulouede JP; Powis J; Bruggmann P; Matthews GV; Kronborg I; Shaw D; Dunlop A; Hellard M; Applegate TL; Crawford S; Dore GJ, 2018, 'Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy', International Journal of Drug Policy, 62, pp. 94 - 103, http://dx.doi.org/10.1016/j.drugpo.2018.10.004
    Journal articles | 2018
    Grebely J; Dalgard O; Conway B; Cunningham EB; Bruggmann P; Hajarizadeh B; Amin J; Bruneau J; Hellard M; Litwin AH; Marks P; Quiene S; Siriragavan S; Applegate TL; Swan T; Byrne J; Lacalamita M; Dunlop A; Matthews GV; Powis J; Shaw D; Thurnheer MC; Weltman M; Kronborg I; Cooper C; Feld JJ; Fraser C; Dillon JF; Read P; Gane E; Dore GJ, 2018, 'Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial', The Lancet Gastroenterology and Hepatology, 3, pp. 153 - 161, http://dx.doi.org/10.1016/S2468-1253(17)30404-1
    Journal articles | 2018
    Jacka B; Bray BC; Applegate TL; Marshall BDL; Lima VD; Hayashi K; DeBeck K; Raghwani J; Harrigan PR; Krajden M; Montaner JSG; Grebely J, 2018, 'Drug use and phylogenetic clustering of hepatitis C virus infection among people who use drugs in Vancouver, Canada: A latent class analysis approach', Journal of Viral Hepatitis, 25, pp. 28 - 36, http://dx.doi.org/10.1111/jvh.12758
    Journal articles | 2018
    Lamoury FMJ; Bajis S; Hajarizadeh B; Marshall AD; Martinello M; Ivanova E; Catlett B; Mowat Y; Marks P; Amin J; Smith J; Ezard N; Cock V; Hayllar J; Persing DH; Kleman M; Cunningham P; Dore GJ; Applegate TL; Grebely J, 2018, 'Evaluation of the Xpert HCV Viral Load Finger-Stick Point-of-Care Assay', Journal of Infectious Diseases, 217, pp. 1889 - 1896, http://dx.doi.org/10.1093/infdis/jiy114
    Journal articles | 2018
    Lamoury FMJ; Hajarizadeh B; Soker A; Martinez D; Quek C; Cunningham P; Catlett B; Cloherty G; Marks P; Amin J; Grebely J; Dore GJ; Applegate TL, 2018, 'Evaluation of a Hepatitis C Virus Core Antigen Assay in Plasma and Dried Blood Spot Samples', Journal of Molecular Diagnostics, 20, pp. 621 - 627, http://dx.doi.org/10.1016/j.jmoldx.2018.05.010
    Journal articles | 2018
    Martinello M; Bhagani S; Gane E; Orkin C; Cooke G; Dore GJ; Petoumenos K; Applegate TL; Tu E; Marks P; Pagani N; Grebely J; Nelson M; Matthews GV, 2018, 'Shortened therapy of eight weeks with paritaprevir/ritonavir/ombitasvir and dasabuvir is highly effective in people with recent HCV genotype 1 infection', Journal of Viral Hepatitis, 25, pp. 1180 - 1188, http://dx.doi.org/10.1111/jvh.12917
    Journal articles | 2018
    Shepherd SJ; McDonald SA; Palmateer NE; Gunson RN; Aitken C; Dore GJ; Goldberg DJ; Applegate TL; Lloyd AR; Hajarizadeh B; Grebely J; Hutchinson SJ, 2018, 'HCV avidity as a tool for detection of recent HCV infection: Sensitivity depends on HCV genotype', Journal of Medical Virology, 90, pp. 120 - 130, http://dx.doi.org/10.1002/jmv.24919
    Journal articles | 2017
    Bajis S; Lamoury F; Applegate TL; Maher L; Treloar C; Mowat Y; Schulz M; Hajarizadeh B; Marshall A; Cunningham E; Cock V; Ezard N; Gorton C; Hayllar J; Smith J; Dore GJ; Grebely J, 2017, 'P4 Acceptability of point of care finger-stick and venepuncture hepatitis C virus testing among people who inject drugs and homeless people', Journal of Virus Eradication, 3, pp. 13 - 14, http://dx.doi.org/10.1016/s2055-6640(20)30745-7
    Journal articles | 2017
    Bartlett SR; Applegate T; Jacka B; Lamoury F; Bull R; Danta M; Bradshaw D; Lloyd AR; Hellard M; Dore GJ; Matthews GV; Grebely J, 2017, 'P6 Phylogenetic clustering of recent hepatitis C virus infection between 2004 and 2015', Journal of Virus Eradication, 3, pp. 14 - 15, http://dx.doi.org/10.1016/s2055-6640(20)30747-0
    Journal articles | 2017
    Bartlett SR; Grebely J; Eltahla AA; Reeves JD; Howe AYM; Miller V; Ceccherini-Silberstein F; Bull RA; Douglas MW; Dore GJ; Harrington P; Lloyd AR; Jacka B; Matthews GV; Wang GP; Pawlotsky JM; Feld JJ; Schinkel J; Garcia F; Lennerstrand J; Applegate TL, 2017, 'Sequencing of hepatitis C virus for detection of resistance to direct-acting antiviral therapy: A systematic review', Hepatology Communications, 1, pp. 379 - 390, http://dx.doi.org/10.1002/hep4.1050
    Journal articles | 2017
    Bartlett SR; Wertheim JO; Bull RA; Matthews GV; Lamoury FMJ; Scheffler K; Hellard M; Maher L; Dore GJ; Lloyd AR; Applegate TL; Grebely J, 2017, 'A molecular transmission network of recent hepatitis C infection in people with and without HIV: Implications for targeted treatment strategies', Journal of Viral Hepatitis, 24, pp. 404 - 411, http://dx.doi.org/10.1111/jvh.12652
    Journal articles | 2017
    Cunningham EB; Hajarizadeh B; Dalgard O; Amin J; Hellard M; Foster GR; Bruggmann P; Conway B; Backmund M; Robaeys G; Swan T; Marks PS; Quiene S; Applegate TL; Weltman M; Shaw D; Dunlop A; Bruneau J; Midgard H; Bourgeois S; Thurnheer MC; Dore GJ; Grebely J; Shaw I; Siriragavan S; Horschik T; Sharma S; Eevers A; Andreassen J; Melkeraaen I; Widder N; Lesneuck K; Kotsoros B; Hazelwood S; Holland R; Axten D; Von Bibra S; Powis J; Mason K; Ryder S; Jack K; Scheidegger C; Huber C; Ferguson C; Staehelin C; Lacalamita M; Fragomeli V; Sevehon A, 2017, 'Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study', BMC Infectious Diseases, 17, pp. 420, http://dx.doi.org/10.1186/s12879-017-2517-3
    Journal articles | 2017
    Eltahla AA; Leung P; Pirozyan MR; Rodrigo C; Grebely J; Applegate T; Maher L; Luciani F; Lloyd AR; Bull RA, 2017, 'Dynamic evolution of hepatitis C virus resistance-associated substitutions in the absence of antiviral treatment', Scientific Reports, 7, pp. 41719, http://dx.doi.org/10.1038/srep41719
    Journal articles | 2017
    Eltahla AA; Rodrigo C; Betz-Stablein B; Grebely J; Applegate T; Luciani F; Schinkel J; Dore GJ; Page K; Bruneau J; Morris MD; Cox AL; Kim AY; Shoukry NH; Lauer GM; Maher L; Hellard M; Prins M; Lloyd AR; Bull RA, 2017, 'Analysis of resistance-associated substitutions in acute hepatitis C virus infection by deep sequencing across six genotypes and three continents', Journal of Viral Hepatitis, 24, pp. 37 - 42, http://dx.doi.org/10.1111/jvh.12615
    Journal articles | 2017
    Grebely J; Applegate TL; Cunningham P; Feld JJ, 2017, 'Hepatitis C point-of-care diagnostics: in search of a single visit diagnosis', Expert Review of Molecular Diagnostics, 17, pp. 1109 - 1115, http://dx.doi.org/10.1080/14737159.2017.1400385
    Journal articles | 2017
    Grebely J; Dalgard O; Conway B; Cunningham E; Bruggmann P; Hajarizadeh B; Amin J; Marks P; Quiene S; Applegate TL; Swan T; Byrne J; Lacalamita M; Dunlop A; Bruneau J; Hellard ME; Matthews GV; Powis J; Shaw D; Thurnheer MC; Weltman M; Kronborg I; Cooper C; Feld JJ; Fraser C; Litwin A; Dillon J; Read P; Gane E; Dore GJ, 2017, 'O13 Efficacy and safety of sofosbuvir/velpatasvir in people with chronic hepatitis C virus infection and recent injecting drug use: the SIMPLIFY study', Journal of Virus Eradication, 3, pp. 5 - 5, http://dx.doi.org/10.1016/s2055-6640(20)30896-7
    Journal articles | 2017
    Grebely J; Dalgard O; Cunningham EB; Hajarizadeh B; Foster GR; Bruggmann P; Conway B; Backmund M; Robaeys G; Swan T; Amin J; Marks PS; Quiene S; Applegate TL; Weltman M; Shaw D; Dunlop A; Hellard M; Bruneau J; Midgard H; Bourgeois S; Staehelin C; Dore GJ, 2017, 'Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study', International Journal of Drug Policy, 47, pp. 177 - 186, http://dx.doi.org/10.1016/j.drugpo.2017.05.020
    Journal articles | 2017
    Grebely J; Lamoury FMJ; Hajarizadeh B; Mowat Y; Marshall AD; Bajis S; Marks P; Amin J; Smith J; Edwards M; Gorton C; Ezard N; Persing D; Kleman M; Cunningham P; Catlett B; Dore GJ; Applegate TL, 2017, 'Evaluation of the Xpert HCV Viral Load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: a cohort study', The Lancet Gastroenterology and Hepatology, 2, pp. 514 - 520, http://dx.doi.org/10.1016/S2468-1253(17)30075-4
    Journal articles | 2017
    Lamoury FMJ; Soker A; Martinez D; Hajarizadeh B; Cunningham EB; Cunningham P; Bruggmann P; Foster GR; Dalgard O; Backmund M; Conway B; Robaeys G; Swan T; Cloherty G; Marks P; Grebely J; Dore GJ; Applegate TL, 2017, 'Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapse', Journal of Clinical Virology, 92, pp. 32 - 38, http://dx.doi.org/10.1016/j.jcv.2017.05.007
    Journal articles | 2017
    Martinello M; Dore GJ; Bopage RI; Finlayson R; Baker D; Bloch M; Filep E; Skurowski J; Lin L; Lamoury F; Bartlett S; Applegate T; Hellard M; Matthews GV, 2017, 'O7 Moving towards HCV elimination in HIV/HCV co- infection in Australia following universal access to interferon-free therapy', Journal of Virus Eradication, 3, pp. 3 - 3, http://dx.doi.org/10.1016/s2055-6640(20)30890-6
    Journal articles | 2017
    Martinello M; Grebely J; Petoumenos K; Gane E; Hellard M; Shaw D; Sasadeusz J; Applegate TL; Dore GJ; Matthews GV, 2017, 'HCV reinfection incidence among individuals treated for recent infection', Journal of Viral Hepatitis, 24, pp. 359 - 370, http://dx.doi.org/10.1111/jvh.12666
    Journal articles | 2017
    Rodrigo C; Eltahla AA; Bull RA; Luciani F; Grebely J; Dore GJ; Applegate T; Page K; Bruneau J; Morris MD; Cox AL; Osburn W; Kim AY; Shoukry NH; Lauer GM; Maher L; Schinkel J; Prins M; Hellard M; Lloyd AR, 2017, 'Phylogenetic analysis of full-length, early infection, hepatitis C virus genomes among people with intravenous drug use: the InC3 Study', Journal of Viral Hepatitis, 24, pp. 43 - 52, http://dx.doi.org/10.1111/jvh.12616
    Journal articles | 2017
    Rodrigo C; Walker MR; Leung P; Eltahla AA; Grebely J; Dore GJ; Applegate T; Page K; Dwivedi S; Bruneau J; Morris MD; Cox AL; Osburn W; Kim AY; Schinkel J; Shoukry NH; Lauer GM; Maher L; Hellard M; Prins M; Luciani F; Lloyd AR; Bull RA, 2017, 'Limited naturally occurring escape in broadly neutralizing antibody epitopes in hepatitis C glycoprotein E2 and constrained sequence usage in acute infection', Infection, Genetics and Evolution, 49, pp. 88 - 96, http://dx.doi.org/10.1016/j.meegid.2017.01.006
    Journal articles | 2016
    Bartlett SR; Jacka B; Bull RA; Luciani F; Matthews GV; Lamoury FMJ; Hellard ME; Hajarizadeh B; Teutsch S; White B; Maher L; Dore GJ; Lloyd AR; Grebely J; Applegate TL, 2016, 'HIV infection and hepatitis C virus genotype 1a are associated with phylogenetic clustering among people with recently acquired hepatitis C virus infection', Infection, Genetics and Evolution, 37, pp. 252 - 258, http://dx.doi.org/10.1016/j.meegid.2015.11.028
    Journal articles | 2016
    Bradshaw D; Raghwani J; Jacka B; Sacks-Davis R; Lamoury F; Down I; Prestage G; Applegate TL; Hellard M; Sasadeusz J; Dore GJ; Pybus OG; Matthews GV; Danta M, 2016, 'Venue-based networks may underpin HCV transmissions amongst HIV-infected gay and bisexual men', PLoS ONE, 11, pp. e0162002, http://dx.doi.org/10.1371/journal.pone.0162002
    Journal articles | 2016
    Eslam M; Mangia A; Berg T; Chan HLY; Irving WL; Dore GJ; Abate ML; Bugianesi E; Adams LA; Najim MAM; Miele L; Weltman M; Mollison L; Cheng W; Riordan S; Fischer J; Romero-Gomez M; Spengler U; Nattermann J; Rahme A; Sheridan D; Booth DR; McLeod D; Powell E; Liddle C; Douglas MW; van der Poorten D; George J; White R; Rojas A; Gallego-Duran R; Bassendine M; Wong VWS; Rosso C; Mezzabotta L; Leung R; Malik B; Matthews G; Applegate T; Grebely J; Fragomeli V; Jonsson JR; Santaro R, 2016, 'Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes', Hepatology, 64, pp. 34 - 46, http://dx.doi.org/10.1002/hep.28475
    Journal articles | 2016
    Hajarizadeh B; Lamoury FMJ; Feld JJ; Amin J; Keoshkerian E; Matthews GV; Hellard M; Dore GJ; Lloyd AR; Grebely J; Applegate TL, 2016, 'Alanine aminotransferase, HCV RNA levels and pro-inflammatory and pro-fibrogenic cytokines/chemokines during acute hepatitis C virus infection', Virology Journal, 13, pp. 32, http://dx.doi.org/10.1186/s12985-016-0482-x
    Journal articles | 2016
    Jacka B; Applegate T; Poon AF; Raghwani J; Harrigan PR; Debeck K; Milloy MJ; Krajden M; Olmstead A; Joy JB; Marshall BDL; Hayashi K; Pybus OG; Lima VD; Magiorkinis G; Montaner J; Lamoury F; Dore GJ; Wood E; Grebely J, 2016, 'Transmission of hepatitis C virus infection among younger and older people who inject drugs in Vancouver, Canada', Journal of Hepatology, 64, pp. 1247 - 1255, http://dx.doi.org/10.1016/j.jhep.2016.02.031
    Journal articles | 2016
    Lamoury FMJ; Hajarizadeh B; Keoshkerian E; Feld JJ; Amin J; Teutsch S; Matthews GV; Hellard M; Dore GJ; Lloyd AR; Applegate TL; Grebely J; Dolan K, 2016, 'HIV infection is associated with higher levels of monocyte chemoattractant protein-1 and eotaxin among people with recent hepatitis C virus infection', BMC Infectious Diseases, 16, pp. 241, http://dx.doi.org/10.1186/s12879-016-1567-2
    Journal articles | 2016
    Martinello M; Gane E; Hellard M; Sasadeusz J; Shaw D; Petoumenos K; Applegate T; Grebely J; Maire L; Marks P; Dore GJ; Matthews GV; Cooper D, 2016, 'Sofosbuvir and ribavirin for 6 weeks is not effective among people with recent hepatitis C virus infection: The DARE-C II study', Hepatology, 64, pp. 1911 - 1921, http://dx.doi.org/10.1002/hep.28844
    Journal articles | 2016
    Martinello M; Hellard M; Shaw D; Petoumenos K; Applegate T; Grebely J; Yeung B; Maire L; Iser D; Lloyd A; Thompson A; Sasadeusz J; Haber P; Dore GJ; Matthews GV, 2016, 'Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: the ATAHC II and DARE-C I studies', ANTIVIRAL THERAPY, 21, pp. 425 - 434, http://dx.doi.org/10.3851/IMP3035
    Journal articles | 2016
    Martinello M; Hellard M; Shaw D; Petoumenos K; Applegate T; Grebely J; Yeung B; Maire L; Iser D; Lloyd A; Thompson A; Sasadeusz J; Haber P; Dore GJ; Matthews GV, 2016, 'Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: the ATAHC II and DARE-C I studies', Antiviral therapy, 21, pp. 465, http://dx.doi.org/10.3851/IMP3073
    Journal articles | 2016
    Rodrigo C; Eltahla AA; Bull RA; Grebely J; Dore GJ; Applegate T; Page K; Bruneau J; Morris MD; Cox AL; Osburn W; Kim AY; Schinkel J; Shoukry NH; Lauer GM; Maher L; Hellard M; Prins M; Estes C; Razavi H; Lloyd AR; Luciani F, 2016, 'Historical Trends in the Hepatitis C Virus Epidemics in North America and Australia', Journal of Infectious Diseases, 214, pp. 1383 - 1389, http://dx.doi.org/10.1093/infdis/jiw389
    Journal articles | 2016
    Sheridan DA; Hajarizadeh B; Fenwick FI; Matthews GV; Applegate T; Douglas M; Neely D; Askew B; Dore GJ; Lloyd AR; George J; Bassendine MF; Grebely J, 2016, 'Maximum levels of hepatitis C virus lipoviral particles are associated with early and persistent infection', Liver International, 36, pp. 1774 - 1782, http://dx.doi.org/10.1111/liv.13176
    Journal articles | 2015
    Applegate TL; Gaudieri S; Plauzolles A; Chopra A; Grebely J; Lucas M; Hellard M; Luciani F; Dore GJ; Matthews GV, 2015, 'Naturally occurring dominant drug resistance mutations occur infrequently in the setting of recently acquired hepatitis C', Antiviral Therapy, 20, pp. 199 - 208, http://dx.doi.org/10.3851/IMP2821
    Journal articles | 2015
    Bradshaw D; Lamoury F; Catlett B; Applegate TL; McAllister J; Dore GJ; Matthews GV; Danta M, 2015, 'A comparison of seminal hepatitis C virus (HCV) RNA levels during recent and chronic HCV infection in HIV-infected and HIV-uninfected individuals', Journal of Infectious Diseases, 211, pp. 736 - 743, http://dx.doi.org/10.1093/infdis/jiu550
    Journal articles | 2015
    Cunningham EB; Applegate TL; Lloyd AR; Dore GJ; Grebely J, 2015, 'Mixed HCV infection and reinfection in people who inject drugs-impact on therapy', Nature Reviews Gastroenterology and Hepatology, 12, pp. 218 - 230, http://dx.doi.org/10.1038/nrgastro.2015.36
    Journal articles | 2015
    Cunningham EB; Jacka B; DeBeck K; Applegate TL; Harrigan PR; Krajden M; Marshall BDL; Montaner J; Lima VD; Olmstead AD; Milloy MJ; Wood E; Grebely J, 2015, 'Methamphetamine injecting is associated with phylogenetic clustering of hepatitis C virus infection among street-involved youth in Vancouver, Canada', Drug and Alcohol Dependence, 152, pp. 272 - 276, http://dx.doi.org/10.1016/j.drugalcdep.2015.04.005
    Journal articles | 2015
    Eslam M; Hashem AM; Leung R; Romero-Gomez M; Berg T; Dore GJ; Chan HLK; Irving WL; Sheridan D; Abate ML; Adams LA; Mangia A; Weltman M; Bugianesi E; Spengler U; Shaker O; Fischer J; Mollison L; Cheng W; Powell E; Nattermann J; Riordan S; McLeod D; Armstrong NJ; Douglas MW; Liddle C; Booth DR; George J; Ahlenstiel G; Ampuero J; Bassendine M; Wong VWS; Rosso C; White R; Mezzabotta L; Suppiah V; Michalk M; Malik B; Matthews G; Applegate T; Grebely J; Fragomeli V; Jonsson JR; Santaro R, 2015, 'Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease', Nature Communications, 6, pp. 6422, http://dx.doi.org/10.1038/ncomms7422
    Journal articles | 2015
    Hajarizadeh B; Grady B; Page K; Kim AY; McGovern BH; Cox AL; Rice TM; Sacks-Davis R; Bruneau J; Morris M; Amin J; Schinkel J; Applegate T; Maher L; Hellard M; Lloyd AR; Prins M; Dore GJ; Grebely J, 2015, 'Patterns of hepatitis C Virus RNA levels during acute infection: The InC3 study', PLoS ONE, 10, pp. e0122232, http://dx.doi.org/10.1371/journal.pone.0122232
    Journal articles | 2015
    Hajarizadeh B; Grady B; Page K; Kim AY; McGovern BH; Cox AL; Rice TM; Sacks-Davis R; Bruneau J; Morris M; Amin J; Schinkel J; Applegate T; Maher L; Hellard M; Lloyd AR; Prins M; Geskus RB; Dore GJ; Grebely J; InC , 2015, 'Factors associated with hepatitis C virus RNA levels in early chronic infection: the InC3 study', Journal of Viral Hepatitis, 22, pp. 708 - 717, http://dx.doi.org/10.1111/jvh.12384
    Journal articles | 2015
    Lamoury FMJ; Bartlett S; Jacka B; Hajarizadeh B; Grebely J; Matthews GV; Dore GJ; Applegate TL, 2015, 'Interferon λ 3 and 4 genotyping using high-resolution melt curve analysis suitable for multiple clinical sample types', Journal of Molecular Diagnostics, 17, pp. 583 - 589, http://dx.doi.org/10.1016/j.jmoldx.2015.05.003
    Journal articles | 2015
    Lamoury FMJ; Jacka B; Bartlett S; Bull RA; Wong A; Amin J; Schinkel J; Poon AF; Matthews GV; Grebely J; Dore GJ; Applegate TL, 2015, 'The influence of hepatitis C virus genetic region on phylogenetic clustering analysis', PLoS ONE, 10, pp. e0131437, http://dx.doi.org/10.1371/journal.pone.0131437
    Journal articles | 2015
    Olmstead AD; Joy JB; Montoya V; Luo I; Poon AFY; Jacka B; Lamoury F; Applegate T; Montaner J; Khudyakov Y; Grebely J; Cook D; Harrigan PR; Krajden M, 2015, 'A molecular phylogenetics-based approach for identifying recent hepatitis C virus transmission events', Infection, Genetics and Evolution, 33, pp. 101 - 109, http://dx.doi.org/10.1016/j.meegid.2015.04.017
    Journal articles | 2014
    Bradshaw D; Applegate T; Dore G; Hellard M; Sasadeusz J; Matthews G; Danta M, 2014, 'The majority of acute HCV infection in HIV-positive men who have sex with men (HIV plus MSM) is transmitted permucosally in the context of HIV serosorting in Australia', HIV MEDICINE, 15, pp. 137 - 137
    Journal articles | 2014
    Bradshaw D; Lamoury F; Catlett B; Mcallister J; Applegate T; Dore G; Matthews G; Danta M, 2014, 'Seminal HCV RNA level may mirror dynamics of plasma HCV RNA in HIV-infected men with acute HCV', HIV MEDICINE, 15, pp. 8 - 8
    Journal articles | 2014
    Hajarizadeh B; Grady B; Page K; Kim AY; McGovern BH; Cox AL; Rice TM; Sacks-Davis R; Bruneau J; Morris M; Amin J; Schinkel J; Applegate T; Maher L; Hellard M; Lloyd AR; Prins M; Geskus RB; Dore GJ; Grebely J; Lauer G; Shoukry NH; Hahn J; Shiboski S; Rice TM; Alavi M; Bouchard R; Aneja J; Teutsch S; White B; Wells B; Zang G; Matthews G; Marks P; Yeung B; Prince LE; Roy E; Bates A; Enriquez J; Chow S; McCredie L; Aitken C; Doyle J; Spelman T; Evans J, 2014, 'Interferon lambda 3 genotype predicts hepatitis C virus RNA levels in early acute infection among people who inject drugs: The InC3 Study', Journal of Clinical Virology, 61, pp. 430 - 434, http://dx.doi.org/10.1016/j.jcv.2014.08.027
    Journal articles | 2014
    Hajarizadeh B; Grebely J; Applegate T; Matthews GV; Amin J; Petoumenos K; Hellard M; Rawlinson W; Lloyd A; Kaldor J; Dore GJ; Dolan K, 2014, 'Dynamics of HCV RNA Levels During Acute Hepatitis C Virus Infection', Journal of Medical Virology, 86, pp. 1722 - 1729, http://dx.doi.org/10.1002/jmv.24010
    Journal articles | 2014
    Jacka B; Applegate T; Krajden M; Olmstead A; Harrigan PR; Marshall BDL; Debeck K; Milloy MJ; Lamoury F; Pybus OG; Lima VD; Magiorkinis G; Montoya V; Montaner J; Joy J; Woods C; Dobrer S; Dore GJ; Poon AFY; Grebely J, 2014, 'Phylogenetic clustering of hepatitis C virus among people who inject drugs in Vancouver, Canada', Hepatology, 60, pp. 1571 - 1580, http://dx.doi.org/10.1002/hep.27310
    Journal articles | 2014
    Savkovic B; Nichols J; Birkett D; Applegate T; Ledger S; Symonds G; Murray JM, 2014, 'A Quantitative Comparison of Anti-HIV Gene Therapy Delivered to Hematopoietic Stem Cells versus CD4+ T Cells', PLoS Computational Biology, 10, http://dx.doi.org/10.1371/journal.pcbi.1003681
    Journal articles | 2013
    Feld JJ; Grebely J; Matthews GV; Applegate T; Hellard M; Sherker A; Cherepanov V; Petoumenos K; Yeung B; Kaldor JM; Lloyd AR; Dore GJ, 2013, 'Plasma interferon-gamma-inducible protein-10 levels are associated with early, but not sustained virological response during treatment of acute or early chronic HCV infection', PLoS ONE, 8, pp. e80003, http://dx.doi.org/10.1371/journal.pone.0080003
    Journal articles | 2013
    Grebely J; Feld JJ; Applegate T; Matthews GV; Hellard M; Sherker A; Petoumenos K; Zang G; Shaw I; Yeung B; George J; Teutsch S; Kaldor JM; Cherepanov V; Bruneau J; Shoukry NH; Lloyd AR; Dore GJ, 2013, 'Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection', Hepatology, 57, pp. 2124 - 2134, http://dx.doi.org/10.1002/hep.26263
    Journal articles | 2013
    Jacka B; Lamoury F; Simmonds P; Dore GJ; Grebely J; Applegate T, 2013, 'Sequencing of the Hepatitis C Virus: A Systematic Review', PLoS ONE, 8, pp. e67073, http://dx.doi.org/10.1371/journal.pone.0067073
    Journal articles | 2012
    Grebely J; Hellard M; Applegate TL; Petoumenos K; Yeung B; Feld J; Rawlinson WD; Lloyd AR; George J; Kaldor JM; Dore GJ; Matthews G; Dolan K, 2012, 'Virological responses during treatment for recent hepatitis C virus: Potential benefit for ribavirin use in HCV/HIV co-infection', AIDS, 26, pp. 1653 - 1661, http://dx.doi.org/10.1097/QAD.0b013e3283553719
    Journal articles | 2011
    Mcintyre GJ; Groneman JL; Yu YH; Tran A; Applegate TL, 2011, 'Multiple shRNA combinations for near-complete coverage of all HIV-1 strains', AIDS Research and Therapy, 8, pp. 1, http://www.aidsrestherapy.com/content/8/1/1
    Journal articles | 2010
    Applegate TL; Birkett DJ; Mcintyre GJ; Jaramillo AB; Symonds G; Murray JM, 2010, 'In silico modeling indicates the development of HIV-1 resistance to multiple shRNA gene therapy differs to standard antiretroviral therapy', Retrovirology, 7:83, pp. 1 - 14, http://www.retrovirology.com/content/7/1/83
    Journal articles | 2010
    Grebely J; Petoumenos K; Hellard M; Matthews G; Suppiah V; Applegate TL; Yeung B; Marks P; Rawlinson WD; Lloyd AROLA; Booth D; Kaldor JM; George J; Dore GJ; Amin J; Cameron B; Acraman B; Dolan K; Bloch M; Van Beek I; Li H; Madden A, 2010, 'Potential Role for Interleukin-28B Genotype in Treatment Decision-Making in Recent Hepatitis C Virus Infection', Hepatology, 52, pp. 1216 - 1224, http://dx.doi.org/10.1002/hep.23850
    Journal articles | 2009
    Mcintyre GJ; Groneman JL; Yu YH; Jaramillo A; Shen S; Applegate TL, 2009, '96 shRNAs designed for maximal coverage of HIV-1 variants', Retrovirology, 6, http://dx.doi.org/10.1186/1742-4690-6-55
    Journal articles | 2009
    Mcintyre GJ; Yu Y; Tran A; Jaramillo AB; Arndt AJ; Millington ML; Boyd MP; Elliott FA; Shen SW; Murray JM; Applegate TL, 2009, 'Cassette deletion in multiple shRNA lentiviral vectors for HIV-1 and its impact on treatment success', Virology Journal, 6, pp. 184, http://www.virologyj.com/content/6/1/184
    Journal articles | 2009
    Millington ML; Arndt A; Boyd MP; Applegate TL; Shen SW, 2009, 'Towards a clinically relevant lentiviral transduction protocol for primary human CD34 hematopoietic stem/progenitor cells', PLoS One, 4, pp. e6461
    Journal articles | 2008
    Mcintyre GJ; Groneman JL; Tran A; Applegate TL, 2008, 'An infinitely expandable cloning strategy plus repeat-proof PCR for working with multiple shRNA', PLoS ONE, 3, http://dx.doi.org/10.1371/journal.pone.0003827
    Journal articles | 2006
    Mokany E; Todd AV; Fuery CJ; Applegate TL, 2006, 'Diagnosis and monitoring of PML-RARalpha-positive acute promyelocytic leukemia by quantitative RT-PCR.', Methods in molecular medicine, 125, pp. 127 - 147
    Journal articles | 2004
    Haber PS; Apte MV; Moran C; Applegate TL; Pirola RC; Korsten MA; Mccaughan GW; Wilson JS, 2004, 'Non-oxidative metabolism of ethanol by rat pancreatic acini', Pancreatology, 4, pp. 82 - 89, http://dx.doi.org/10.1159/000077608
    Journal articles | 2002
    Applegate TL; Iland HJ; Mokany E; Todd AV, 2002, 'Diagnosis and molecular monitoring of acute promyelocytic leukemia using DzyNA reverse transcription-PCR to quantify PML/RARα fusion transcripts', Clinical Chemistry, 48, pp. 1338 - 1343, http://dx.doi.org/10.1093/clinchem/48.8.1338
    Journal articles | 2002
    Applegate TL; Iland HJ; Mokany E; Todd AV, 2002, 'Molecular monitoring of acute promyelocytic leukemia by DzyNA reverse transcription-PCR', CLINICAL CHEMISTRY, 48, pp. 1858 - 1860, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000178238100041&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2001
    End DW; Smets G; Todd AV; Applegate TL; Fuery CJ; Angibaud P; Venet M; Sanz G; Poignet H; Skrzat S; Devine A; Wouters W; Bowden C, 2001, 'Characterization of the antitumor effects of the selective farnesyl protein transferase inhibitor R115777 in vivo and in vitro', Cancer Research, 61, pp. 131 - 137
    Journal articles | 2000
    Fuery CJ; Impey H; Roberts NK; Applegate TL; Ward RL; Hawkins NJ; Sheehan C; O Grady R; Todd AV, 2000, 'Detection of rare mutant alleles by restriction endonuclease-mediated selective-PCR: assay design and optimization', Clinical Chemistry, 46, pp. 620 - 624
    Journal articles | 2000
    Impey HL; Applegate TL; Haughton MA; Fuery CJ; King JE; Todd AV, 2000, 'Factors that influence deoxyribozyme cleavage during polymerase chain reaction', Analytical Biochemistry, 286, pp. 300 - 303, http://dx.doi.org/10.1006/abio.2000.4818
    Journal articles | 2000
    Todd AV; Fuery CJ; Impey HL; Applegate TL; Haughton MA, 2000, 'DzyNA-PCR: Use of DNAzymes to detect and quantify nucleic acid sequences in a real-time fluorescent format', Clinical Chemistry, 46, pp. 625 - 630, http://dx.doi.org/10.1093/clinchem/46.5.625
    Journal articles | 2000
    Ward RL; Sheehan C; Norrie M; Applegate TL; Fuery CJ; Impey H; Hawkins NJ; Todd AV, 2000, 'Factors influencing the detection of mutant K-ras in the serum of patients with colorectal cancer', Annals of the New York Academy of Sciences, 906, pp. 17 - 18, http://dx.doi.org/10.1111/j.1749-6632.2000.tb06583.x
    Journal articles | 1999
    Roberts NJ; Impey H; Applegate TL; Furey C; Ward RL; Todd AV, 1999, 'Rapid and sensitive detection of mutant alleles in codon 12 of K-ras by restriction endonuclease-mediated selective polymerase chain reaction (REMS-PCR)', BioTechniques, 27, pp. 418 - 422
    Journal articles | 1998
    Apte MV; Haber PS; Applegate TL; Norton ID; Mccaughan GW; Korsten MA; Pirola RC; Wilson JS, 1998, 'Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture', Gut, pp. 128 - 133, http://dx.doi.org/10.1136/gut.43.1.128
    Journal articles | 1998
    Apte MV; Norton ID; Haber PS; Applegate TL; Mccaughan GW; Korsten MA; Pirola RC; Wilson JS, 1998, 'The effect of ethanol on pancreatic enzymes - a dietary artefact?', Biochimica et Biophysica ACTA, 1379, pp. 314 - 324, http://dx.doi.org/10.1016/S0304-4165(97)00109-8
    Journal articles | 1998
    Haber PS; Apte MV; Applegate TL; Norton ID; Korsten MA; Pirola R; Wilson JS, 1998, 'Metabolism of ethanol by rat pancreatic acinar cells', Journal of Laboratory and Clinical Medicine, 132, pp. 203 - 294, http://linkinghub.elsevier.com/retrieve/pii/S0022-2143(98)90042-7
    Journal articles | 1998
    Haber PS; Apte MV; Applegate TL; Norton ID; Korsten MA; Pirola RC; Wilson JS, 1998, 'Metabolism of ethanol by rat pancreatic acinar cells', Journal of Laboratory and Clinical Medicine, 132, pp. 294 - 302, http://dx.doi.org/10.1016/S0022-2143(98)90042-7
    Journal articles | 1997
    Applegate TL; Karjalainen A; Bygrave FL, 1997, 'Rapid Ca2+ influx induced by the action of dibutylhydroquinone and glucagon in the perfused rat liver', Biochemical Journal, 323, pp. 463 - 467, http://dx.doi.org/10.1042/bj3230463
  • Conference Presentations | 2023
    Hengel B; Causer L; Smith K; Applegate T; Patel P; Cooney L; Andrewartha K; Papa R; Hui B; Regan D; Matthews S; Guy R, 2023, 'Public health impact of molecular POC testing for COVID-19 in remote Aboriginal and Torres Strait Islander communities during the pandemic in Australia', presented at 1st Australasian conference on point of care testing for infectious diseases, Sheraton Grand Sydney Hyde Park, 14 March 2023 - 15 August 2023, https://az659834.vo.msecnd.net/eventsairaueprod/production-ashm-public/fef20648acf947ad8041df1c63571040
    Conference Presentations | 2023
    Patel P; Applegate T; Andrewartha K; Causer L; Saha A; Kindinger A; Law H; Borgnolo B; Miller A; Martinez M; Crowley H; Williams A; Bodiyabadu K; Verich A; Khawar L; Alternetti N; Jayasinghe I; Matthews S; Guy R, 2023, '“It’s positive- now what?”: Developing systems to enable real-time public health action in a large decentralised remote and regional COVID-19 point of care testing program', presented at 1st Australasian Conference on Point of Care Testing for Infectious Diseases, 14 March 2023 - 15 March 2023, https://az659834.vo.msecnd.net/eventsairaueprod/production-ashm-public/fa5b04cb2e4d4415806861f08a29540f
    Conference Posters | 2022
    Hengel B; Causer L; Matthews S; Applegate T; Anderson L; Patel P; Smith K; Andrewartha K; Guy R, 2022, 'Aboriginal and Torres Strait Islander COVID-19 point-of-care testing program: Test positivity over time 2020-2022', Sydney, presented at 2nd Australasian COVID-19 Conference, Sydney, 21 July 2022 - 22 July 2022, https://az659834.vo.msecnd.net/eventsairaueprod/production-ashm-public/cf60e0bb3faf4c7dacc6b8b0dba1bbab
    Conference Abstracts | 2019
    Grebely J; Cunningham EB; Dalgard O; Hajarizadeh B; Conway B; Powis J; Bruneau J; Feld J; Read P; Cooper C; Amin J; Bruggmann P; Lacombe K; Stedman C; Hellard M; Marks P; Dunlop A; Moriggia A; Applegate T; Litwin A; Matthews G; Dore G, 2019, 'Reinfection following successful HCV DAA therapy among people with recent injecting drug use', in JOURNAL OF HEPATOLOGY, ELSEVIER, AUSTRIA, Vienna, Vol. 70, pp. E732 - E733, presented at International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), AUSTRIA, Vienna, 10 April 2019 - 14 April 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000463481703222&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2019
    Hooshyar SH; Martinello M; Yee J; Bartlett S; Read P; Baker D; Post J; Finlayson R; Bloch M; Doyle J; Shaw D; Hellard M; Petoumenos K; Marks P; Applegate T; Dore G; Matthew G, 2019, 'Low HCV reinfection incidence following DAA treatment scale-up in people living with HIV in Australia', in JOURNAL OF HEPATOLOGY, ELSEVIER, AUSTRIA, Vienna, Vol. 70, pp. E734 - E734, presented at International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), AUSTRIA, Vienna, 10 April 2019 - 14 April 2019
    Conference Abstracts | 2019
    Matthews G; Bhagani S; Van der Valk M; Rockstroh JK; Kim AY; Thurnheer C; Feld JJ; Bruneau J; Gane EJ; Hellard M; Grebely J; Applegate T; Marks P; Martinello M; Petoumenos K; Dore G, 2019, 'SHORT COURSE DURATION SOFOSBUVIR/VELPATASVIR IS INFERIOR TO STANDARD DURATION THERAPY IN THE TREATMENT OF RECENTLY ACQUIRED HCV INFECTION: RESULTS FROM REACT STUDY', in HEPATOLOGY, WILEY, MA, Boston, Vol. 70, pp. 1487A - 1488A, presented at 70th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, MA, Boston, 08 November 2019 - 12 November 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000500824000056&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2019
    Walsh KW; Martinello M; Churkin A; Lou S; Applegate T; Etzion O; Uprichard SL; Cotler SJ; Barash D; Matthews G; Dahari H, 2019, 'MODELING INDICATES 100% NEGATIVE PREDICTIVE VALUE OF ACHIEVING CURE IN SUBJECTS WITH RECENT HCV INFECTION TREATED FOR 6 WEEKS WITH SOFOSBUVIR AND RIBAVIRIN: THE DARE II STUDY', in HEPATOLOGY, WILEY, MA, Boston, pp. 969A - 970A, presented at Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, MA, Boston, 08 November 2019 - 12 November 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000488653503298&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2018
    Artenie AA; Cunningham E; Conway B; Dalgard O; Powis J; Bruggmann P; Hellard M; Cooper C; Read P; Feld JJ; Hajarizadeh B; Amin J; Applegate TL; Dillon JF; Fraser C; Gane E; Litwin AH; Marks P; Matthews GV; Quiene S; Thurnheer MC; Weltman M; Dore G; Bruneau J; Grebely J, 2018, 'Drug and alcohol use patterns during and following treatment with sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use: Insights from trajectory analyses', in JOURNAL OF VIRAL HEPATITIS, WILEY, CANADA, Toronto, pp. 31 - 32, presented at 16th International Symposium on Viral Hepatitis and Liver Diseases (ISVHLD), CANADA, Toronto, 14 June 2018 - 17 June 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000435101000046&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2018
    Dalgard O; Grebely J; Conway B; Cunningham E; Bruggmann P; Hajarizadeh B; Amin J; Marks P; Quiene S; Applegate TL; Swan T; Byrne J; Lacalamita M; Dunlop A; Bruneau J; Hellard ME; Matthews GV; Powis J; Shaw D; Thurnheer MC; Weltman M; Kronborg I; Cooper C; Feld JJ; Fraser C; Litwin A; Dillon J; Read P; Gane E; Dore GJ, 2018, 'Sofosbuvir and Velpatasvir for Hepatitis C Virus Infection in People with Recent Injecting Drug Use (Simplify): An Open-Label, Single-Arm, Phase 4, Multicentre Trial', in HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, PACINI EDITORE, Vol. 20, pp. 14 - 14, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000440974900004&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2018
    Howe A; Cento V; Knight N; Dietz J; Di Maio VC; De Salazar A; Popping S; Fourati S; Knops E; Kjellin M; Sayan M; Mor O; De Knegt RJ; Mitchell R; Tam EV; Pai R; Pereira OOC; Lennerstrand J; Wang GP; Wong A; Parczewski M; Applegate T; Ramji A; Perno CF; Kaiser R; Boucher CAB; Feld JJ; Pawlotsky J-M; Garcia F; Ceccherini-Silberstein F; Sarrazin C; Harrigan R, 2018, 'A Real World Resistance Profile of Virologic Failures Collected from an International Collaboration (SHARED)', in HEPATOLOGY, WILEY, CA, San Francisco, pp. 128A - 128A, presented at Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, CA, San Francisco, 09 November 2018 - 13 November 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000446020500205&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2018
    Lamoury F; Bajis S; Hajarizadeh B; Marshall A; Martinello M; Ivanova E; Catlett B; Mowat Y; Marks P; Amin J; Smith J; Ezard N; Cock V; Hayllar J; Persing D; Kleman M; Cunningham P; Dore G; Applegate T; Grebely J, 2018, 'Evaluation of the Xpert fingerstick HCV viral load assay', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, FRANCE, Paris, pp. S167 - S167, presented at International Liver Congress (ILC), FRANCE, Paris, 11 April 2018 - 15 April 2018, http://dx.doi.org/10.1016/S0168-8278(18)30546-4
    Conference Papers | 2018
    Lamoury F; Bajis S; Martinez D; Mowat Y; Jayasinghe I; Martinez M; Cunningham P; Catlett B; Jacka B; Marks P; Grebely J; Cloherty G; Dore G; Applegate T, 2018, 'Evaluation of a hepatitis C virus core antigen assay in dried-blood spots: a cohort study', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, FRANCE, Paris, pp. S317 - S318, presented at International Liver Congress (ILC), FRANCE, Paris, 11 April 2018 - 15 April 2018, http://dx.doi.org/10.1016/S0168-8278(18)30854-7
    Conference Abstracts | 2018
    Martinello M; Bartlett S; Dore G; Bopage R; Finlayson R; Baker D; Bloch M; Doyle J; Shaw D; Hajkowicz K; Read P; Filep E; Lin L; Yee J; Applegate T; Hellard M; Matthews G, 2018, 'Universal access to DAA therapy paves the way for HCV control and elimination among people living with HIV in Australia', in Universal access to DAA therapy paves the way for HCV control and elimination among people living with HIV in Australia, Paris, France, presented at THE INTERNATIONAL LIVER CONGRESS 2018, Paris, France, 11 April 2018 - 15 April 2018
    Conference Abstracts | 2018
    Martinello M; Cerrone M; Bhagani S; Gane E; Orkin C; Cooke G; Dore GJ; Petoumenos K; Applegate TL; Tu E; Marks P; Pagani N; Schoolmeesters A; Grebely J; Nelson M; Matthews GV, 2018, 'TARGET3D: high efficacy of 8 weeks paritaprevir/ritonavir/ombitasvir and dasabuvir among people with recent genotype 1 HCV infection', in HIV MEDICINE, WILEY, Vol. 19, pp. S151 - S152, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000430174700440&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2017
    Bartlett SR; Grebely J; Eltahla AA; Reeves JD; Howe A; Miller V; Bull RA; Ceccherini-Silberstein F; Douglas MW; Dore GJ; Harrington P; Lloyd AR; Jacka B; Matthews GV; Wang GP; Pawlotsky J-M; Feld JJ; Schinkel J; Garcia F; Lennerstrand J; Applegate TL, 2017, 'Systematic review & expert guidance on methods for sequencing of hepatitis C virus for detection of direct-acting antiviral resistance', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, NETHERLANDS, Amsterdam, Vol. 66, pp. S323 - S323, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, NETHERLANDS, Amsterdam, 19 April 2017 - 23 April 2017, http://dx.doi.org/10.1016/S0168-8278(17)30970-4
    Theses / Dissertations | 2017
    Bartlett SR, 2017, Molecular epidemiology of recently acquired hepatitis C virus infection in Australia
    Conference Abstracts | 2017
    Grebely J; Dalgard O; Conway B; Cunningham E; Bruggmann P; Hajarizadeh B; Amin J; Marks P; Quiene S; Applegate TL; Swan T; Byrne J; Lacalamita M; Dunlop AJ; Bruneau J; Hellard ME; Matthews GV; Powis J; Shaw D; Thurnheer CM; Weltman M; Kronborg I; Cooper C; Feld JJ; Fraser C; Litwin A; Dillon J; Read P; Gane E; Dore GJ, 2017, 'Efficacy and safety of sofosbuvir/velpatasvir in people with chronic hepatitis C virus infection and recent injecting drug use: the SIMPLIFY study', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, NETHERLANDS, Amsterdam, Vol. 66, pp. S513 - S513, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, NETHERLANDS, Amsterdam, 19 April 2017 - 23 April 2017
    Conference Abstracts | 2017
    Grebely J; Dalgard O; Conway B; Cunningham E; Bruggmann P; Hajarizadeh B; Amin J; Marks P; Quiene S; Applegate TL; Swan T; Byrne J; Lacalamita M; Dunlop AJ; Bruneau J; Hellard ME; Matthews GV; Powis J; Shaw D; Thurnheer MC; Weltman M; Kronborg I; Cooper C; Feld JJ; Fraser C; Litwin AH; Dillon JF; Read P; Gane ED; Dore GJ, 2017, 'EFFICACY AND SAFETY OF SOFOSBUVIR/VELPATASVIR IN PEOPLE WITH CHRONIC HEPATITIS C VIRUS INFECTION AND RECENT INJECTING DRUG USE: THE SIMPLIFY STUDY', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 36, pp. 34 - 34, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000424000500085&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2017
    Grebely J; Lamoury F; Hajarizadeh B; Mowat Y; Marshall A; Bajis S; Marks P; Amin J; Smith J; Edwards M; Gorton C; Ezard N; Persing D; Kleman M; Cunningham P; Catlett B; Dore G; Applegate TL, 2017, 'Field evaluation of Xpert (R) HCV Viral Load point-of-care test for detection of hepatitis C virus infection by venipuncture-collected and finger-stick capillary whole-blood samples', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, NETHERLANDS, Amsterdam, pp. S709 - S709, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, NETHERLANDS, Amsterdam, 19 April 2017 - 23 April 2017, http://dx.doi.org/10.1016/S0168-8278(17)31900-1
    Conference Abstracts | 2017
    Lamoury FM; Hajarizadeh B; Soker A; Martinez D; Quek C; Cunningham P; Catlett B; Cloherty GA; Marks P; Amin J; Grebely J; Dore GJ; Applegate TL, 2017, 'Hepatitis C virus core antigen and dried blood spots as simplified hepatitis C virus diagnostic tools', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, NETHERLANDS, Amsterdam, Vol. 66, pp. S710 - S710, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, NETHERLANDS, Amsterdam, 19 April 2017 - 23 April 2017, http://dx.doi.org/10.1016/S0168-8278(17)31901-3
    Conference Abstracts | 2016
    Grebely J; Marshall AD; Krahe M; Erratt A; Telenta J; Treloar C; Jones SC; Adey S; Bath N; How-Chow D; Byrne J; Harvey P; Dunlop AJ; Applegate TL; Lamoury F; Mowat Y; Jauncey M; Read P; Gilliver R; Smith J; Collie T; Dore GJ, 2016, 'A LIVER HEALTH PROMOTION INTERVENTION INTEGRATING NON-INVASIVE LIVER DISEASE SCREENING IN DRUG AND ALCOHOL SETTINGS: THE LIVERLIFE STUDY', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 40 - 40
    Conference Papers | 2016
    Lamoury F; Hajarizadeh B; Martinello M; Soker A; Martinez D; Cunningham P; Cloherty GA; Marks P; Matthews G; Amin J; Grebely J; Dore G; Applegate TL, 2016, 'Hepatitis C virus core antigen: A simplified treatment monitoring tool among those with recent Hepatitis C virus infection, including for post-treatment relapse', in HEPATOLOGY, WILEY, MA, Boston, pp. 415A - 415A, presented at 67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), MA, Boston, 11 November 2016 - 15 November 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000385493802113&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Presentations | 2016
    Lamoury F; Soker A; Martinez D; Hajarizadeh B; Cunningham E; Bruggmann P; Foster G; Dalgard O; Conway B; Robaeys G; Swan T; Backmund M; Marks P; Grebely J; Dore GJ; Applegate TL, 2016, 'HEPATITIS C VIRUS CORE ANTIGEN: A SIMPLIFIED TREATMENT MONITORING TOOL, INCLUDING FOR POST-TREATMENT RELAPSE', presented at EASL International Liver Congress, SPAIN, Barcelona, 13 April 2016 - 17 April 2016, http://dx.doi.org/10.1016/S0168-8278(16)01163-6
    Conference Abstracts | 2016
    Martinello M; Petoumenos K; Grebely J; Gane E; Hellard M; Shaw D; Sasdeusz J; Applegate T; Lamoury F; Yeung B; Maire L; Dore G; Matthews G, 2016, 'INCIDENCE OF HCV REINFECTION AMONG TREATED INDIVIDUALS WITH RECENTLY ACQUIRED INFECTION', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, SPAIN, Barcelona, Vol. 64, pp. S620 - S621, presented at EASL International Liver Congress, SPAIN, Barcelona, 13 April 2016 - 17 April 2016, http://dx.doi.org/10.1016/S0168-8278(16)01152-1
    Conference Posters | 2015
    Olmstead AD; Montoya V; Joy J; Poon AF; Jacka B; Lamoury F; Applegate T; Monaner J; Khudyakov Y; Grebely J; Cook D; Harrigan PR; Krajden M, 2015, 'Characterizing hepatitis C virus transmission dynamics using molecular phylogenetic-based methods', GERMANY, Berlin, Vol. 22, pp. 60 - 60, presented at 15th International Symposium on Viral Hepatitis and Liver Diseases (ISVHLD), GERMANY, Berlin, 26 June 2015 - 28 June 2015, http://dx.doi.org/10.1111/jvh.76_12425
    Conference Papers | 2014
    Bradshaw D; Jacka B; Sacks-Davis R; Lamoury F; Applegate T; Dore G; Down I; Luciani F; Hellard M; Sasadeusz J; Danta M; Matthews G, 2014, 'A novel method comparing sexual networks with the HCV phylogeny in HIV-positive MSM with acute HCV infection identifies two potential intervention targets for permucosally transmitted HCV in Australia', in HIV MEDICINE, WILEY-BLACKWELL, pp. 136 - 136
    Conference Papers | 2014
    Hajarizadeh B; Grady B; Page K; Kim AY; Mcgovern BH; Cox AL; Rice TM; Sacks-Davis R; Bruneau J; Morris M; Amin J; Schinkel J; Applegate T; Maher L; Hellard M; Lloyd AR; Prins M; Geskus RB; Dore GJ; Grebely J, 2014, 'Factors associated with hepatitis C virus RNA levels in early chronic infection: The InC3 study', in Journal of Viral Hepatitis, Blackwell Publishing Ltd, MA, Boston, pp. 708 - 717, presented at 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 07 November 2014 - 11 November 2014, http://dx.doi.org/10.1111/jvh.12384
    Conference Papers | 2014
    Hajarizadeh B; Grady BP; Page K; Kim AY; McGovern BH; Cox A; Rice TM; Sacks-Davis R; Bruneau J; Morris MD; Amin J; Schinkel J; Applegate TL; Maher L; Hellard M; Lloyd AR; Prins M; Dore GJ; Grebely J, 2014, 'Patterns of hepatitis C virus RNA levels during acute infection: the InC3 study', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 898A - 899A, presented at 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 07 November 2014 - 11 November 2014
    Conference Papers | 2014
    Jacka B; Applegate T; Poon AF; Harrigan R; Dore GJ; Olmstead A; DeBeck K; Milloy M-J; Lamoury F; Woods C; Brumme Z; Dobrer S; Lima VD; Montaner J; Joy J; Marshall BD; Kerr T; Wood E; Krajden M; Grebely J, 2014, 'P762 TEMPORAL CHANGES IN HEPATITIS C VIRUS GENOTYPE 3A DISTRIBUTION AMONG PEOPLE WHO INJECT DRUGS IN VANCOUVER, CANADA', in Journal of Hepatology, Elsevier, ENGLAND, London, pp. s324 - s325, presented at 49th Annual International Liver Congress of the European-Association-for-the-Study-of-the-Liver, ENGLAND, London, 09 April 2014 - 13 April 2014, http://dx.doi.org/10.1016/s0168-8278(14)60923-5
    Conference Papers | 2014
    Jacka B; Poon A; Applegate TL; Krajden M; Olmstead A; Harrigan R; Marshall BD; DeBeck K; Milloy M-J; Lamoury F; Pybus O; Lima V; Magiorkinis G; Montoya V; Montaner J; Joy J; Dore GJ; Kerr T; Wood E; Grebely J, 2014, 'Hepatitis C virus network dynamics among people who inject drugs in Vancouver, Canada', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 907A - 908A, presented at 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 07 November 2014 - 11 November 2014
    Conference Papers | 2014
    Martinello M; Hellard M; Shaw D; Petoumenos K; Applegate T; Grebely J; Yeung B; Maire L; Iser D; Lloyd A; Thompson A; Sasadeusz J; Haber P; Dore GJ; Matthews GV, 2014, 'Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: The ATAHC II and DARE-C i studies', in Antiviral Therapy, SAGE Publications, MA, Boston, pp. 425 - 434, presented at 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 07 November 2014 - 11 November 2014, http://dx.doi.org/10.3851/IMP3035
    Conference Papers | 2014
    Olmstead A; Montoya V; Joy J; Luo I; Janjua NZ; Poon A; Jacka B; Lamoury F; Applegate TL; Grebely J; Harrigan R; Krajden M, 2014, 'Molecular sequencing and phylogenetics as enhanced surveillance tools for monitoring Hepatitis C virus transmission dynamics in British Columbia', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 283A - 283A, presented at 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 07 November 2014 - 11 November 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344483801103&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2014
    Sheridan DA; Hajarizadeh B; Matthews G; Applegate TL; Douglas MW; Askew B; Neely D; Bassendine MF; Dore GJ; Lloyd AR; George J; Grebely J, 2014, 'Hepatitis C lipoviral particle levels are associated with spontaneous clearance of acute infection', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 929A - 929A, presented at 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 07 November 2014 - 11 November 2014
    Conference Papers | 2013
    Bradshaw D; Jacka B; Sacks-Davis R; Lamoury F; Applegate TL; Dore GJ; Down I; Luciani F; Hellard M; Sasadeusz J; Danta M; Matthews G, 2013, 'A novel method comparing sexual networks with the HCV phylogeny in HIV-positive men who have sex with men (MSM) with acute HCV infection identifies two potential intervention targets for permucosally-transmitted HCV', in HEPATOLOGY, WILEY-BLACKWELL, DC, Washington, pp. 1307A - 1307A, presented at 64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, DC, Washington, 01 November 2013 - 05 November 2013
    Conference Papers | 2013
    Bradshaw D; Lamoury F; Catlett B; Applegate TL; Mcallister J; Dore GJ; Matthews G; Danta M, 2013, 'Seminal HCV RNA level may mirror dynamics of plasma HCV RNA in HIV-positive men with acute HCV infection', in HEPATOLOGY, WILEY-BLACKWELL, DC, Washington, pp. 913A - 913A, presented at 64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, DC, Washington, 01 November 2013 - 05 November 2013
    Conference Papers | 2013
    Jacka B; Lamoury F; Simmonds P; Dore GJ; Grebely J; Applegate T, 2013, 'SEQUENCING THE HEPATITIS C VIRUS: A SYSTEMATIC REVIEW', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, NETHERLANDS, Amsterdam, pp. S471 - S472, presented at International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), NETHERLANDS, Amsterdam, 24 April 2013 - 28 April 2013, http://dx.doi.org/10.1016/S0168-8278(13)61160-5
    Conference Papers | 2012
    Grebely J; Feld JJ; Applegate T; Matthews G; Hellard M; Sherker A; Petoumenos K; Shaw I; Yeung B; Kaldor JM; Cherepanov V; Bruneau J; Lloyd A; Shoukry N; Dore G, 2012, '889 PLASMA IP10 LEVEL PREDICTS SPONTANEOUS CLEARANCE IN ACUTE HCV INFECTION', in Journal of Hepatology, Elsevier, SPAIN, Barcelona, pp. s346, presented at 47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), SPAIN, Barcelona, 18 April 2012 - 22 April 2012, http://dx.doi.org/10.1016/s0168-8278(12)60901-5
    Conference Papers | 2011
    Applegate T; Gaudieri S; Pham S; White P; Grebely J; Hellard M; Suppiah V; George J; Lloyd A; Dore G; Matthews GV, 2011, 'Impact of host and viral characteristics on treatment outcome within hepatitis C transmission clusters in HIV-positive individuals with recently acquired HCV', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, pp. A87 - A87, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000687677600071&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2011
    Applegate T; Gaudieri S; Pham S; White P; Grebely J; Hellard M; Suppiah V; George J; Lloyd A; Dore G; Matthews GV, 2011, 'Impact of host and viral characteristics on treatment outcome within hepatitis C transmission clusters in HIV-positive individuals with recently acquired HCV', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, Los Cabos, MEXICO, pp. A87 - A87, presented at International Workshop on HIV and Hepatitis Virus Drug Resistance and Curative Strategies, Los Cabos, MEXICO, 07 June 2011 - 11 June 2011, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000294375700092&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2011
    Feld JJ; Grebely J; Applegate T; Matthews GV; Hellard M; Suppiah V; Sherker A; Petoumenos K; Shaw I; Yeung B; Rawlinson W; Booth D; Kaldor JM; Lloyd AR; Dore GJ, 2011, 'IP-10 IS ASSOCIATED WITH EARLY VIRAL KINETICS, BUT NOT SUSTAINED VIROLOGICAL RESPONSE DURING TREATMENT FOR RECENT HEPATITIS C VIRUS INFECTION', in JOURNAL OF HEPATOLOGY, ELSEVIER, GERMANY, Berlin, pp. S455 - S455, presented at 46th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), GERMANY, Berlin, 30 March 2011 - 03 April 2011, http://dx.doi.org/10.1016/S0168-8278(11)61154-9
    Conference Papers | 2011
    Gaudieri S; Applegate T; Tschochner M; Plauzolles A; Pfafferott K; Lucas M; Diepolder H; Ulsenheimer A; Mallal S; Grebely J; Hellard M; Lloyd A; Kaldor J; Dore G; Matthews GV, 2011, 'Signature resistance mutations to directly acting antiviral agents occur at low prevalence in treatment-naive subjects with recently acquired hepatitis C infection', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, pp. A86 - A86, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000687677600070&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2011
    Gaudieri S; Applegate T; Tschochner M; Plauzolles A; Pfafferott K; Lucas M; Diepolder H; Ulsenheimer A; Mallal S; Grebely J; Hellard M; Lloyd A; Kaldor J; Dore G; Matthews GV, 2011, 'Signature resistance mutations to directly acting antiviral agents occur at low prevalence in treatment-naive subjects with recently acquired hepatitis C infection', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, Los Cabos, MEXICO, pp. A86 - A86, presented at International Workshop on HIV and Hepatitis Virus Drug Resistance and Curative Strategies, Los Cabos, MEXICO, 07 June 2011 - 11 June 2011, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000294375700091&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2011
    Gaudieri S; Applegate T; Tshochner M; Plauzolles A; Pfafferott K; Lucas M; Diepolder H; Ulsenheimer A; Mallal S; Grebely J; Hellard M; Lloyd A; Kaldor J; Dore G; Matthews G, 2011, 'SIGNATURE RESISTANCE MUTATIONS TO DIRECTLY ACTING ANTIVIRAL AGENTS OCCUR AT LOW PREVALENCE IN TREATMENT NAIVE SUBJECTS WITH RECENTLY ACQUIRED HEPATITIS C INFECTION', in JOURNAL OF HEPATOLOGY, ELSEVIER, GERMANY, Berlin, pp. S184 - S185, presented at 46th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), GERMANY, Berlin, 30 March 2011 - 03 April 2011, http://dx.doi.org/10.1016/S0168-8278(11)60455-8
    Conference Papers | 2011
    Grebely J; Matthews GV; Hellard M; Suppiah V; Petoumenos K; Applegate T; Yeung B; Rawlinson W; Feld J; Lloyd AR; Booth D; Kaldor JM; George J; Dore GJ, 2011, 'IL28B GENOTYPE HAS VARIABLE INFLUENCE ON EARLY VIRAL KINETICS, BUT NO INFLUENCE ON SUSTAINED VIROLOGICAL RESPONSE DURING TREATMENT FOR RECENT HEPATITIS C VIRUS INFECTION', in JOURNAL OF HEPATOLOGY, ELSEVIER, GERMANY, Berlin, pp. S524 - S524, presented at 46th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), GERMANY, Berlin, 30 March 2011 - 03 April 2011, http://dx.doi.org/10.1016/S0168-8278(11)61330-5
    Conference Papers | 2011
    Matthews G; Applegate TL; Tschochner M; Plauzolles A; Mallal SA; Grebely J; Hellard M; Lloyd AR; Kaldor JM; Dore GJ; Gaudieri S, 2011, 'ULTRA DEEP SEQUENCING ANALYSIS OF TREATMENT NAIVE INDIVIDUALS WITH RECENTLY ACQUIRED HEPATITIS C INFECTION DEMONSTRATES WIDESPREAD AMINO ACID VARIATION AT KEY PROTEASE AND POLYMERASE SITES OCCURRING AT LOW FREQUENCY', in HEPATOLOGY, WILEY-BLACKWELL, CA, San Francisco, pp. 1343A - 1344A, presented at 62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), CA, San Francisco, 04 November 2011 - 08 November 2011, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000295578004555&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2003
    Iland H; Bradstock K; Chong L; Springall F; Ayling J; Catalano A; Supple S; Todd A; Applegate T; Mokany E, 2003, 'Results of the APML3 trial of ATRA, intensive idarubicin, and triple maintenance combined with molecular monitoring in acute promyelocytic leukaemia (APL): A study by the Australasian leukaemia and lymphoma group (ALLG).', in BLOOD, AMER SOC HEMATOLOGY, CALIFORNIA, SAN DIEGO, pp. 141A - 141A, presented at 45th Annual Meeting of the American-Society-of-Hematology, CALIFORNIA, SAN DIEGO, 06 December 2003 - 09 December 2003, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000186536700484&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 1999
    Todd AV; Impey HL; Applegate TL; Haughton MA; Fuery CJ, 1999, 'Homogeneous amplification and detection of nucleic acid sequences using DzyNA (TM)-PCR.', in CLINICAL CHEMISTRY, AMER ASSOC CLINICAL CHEMISTRY, pp. 2049 - 2050, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000083440300053&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 1997
    Apte M; Norton I; Haber P; Applegate T; McCaughan G; Korsten M; Pirola R; Wilson J, 1997, 'Ethanol-induced increases in pancreatic enzyme content - A dietary artefact?', in Gastroenterology, WB Saunders, pp. A426 - A426, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997WV41901695&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 1997
    Apte MV; Haber PS; Applegate TL; Norton ID; Korsten MA; Pirola RC; Wilson JS, 1997, 'Generation of fatty acid ethyl esters by rat pancreatic acini: Comparison of oxidative and non-oxidative ethanol metabolism', in Gastroenterology, W B SAUNDERS CO-ELSEVIER INC, pp. A426 - A426, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997WV41901697&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 1997
    Apte MV; Haber PS; Applegate TL; Norton ID; Korsten MA; Unknown ; Wilson JS, 1997, 'Generation of fatty acid ethyl esters by rat pancreatic acini: comparison of oxidative and non-oxidative ethanol metabolism', in Gastroenterology, W B Saunders Co, Philadelphia, PA, USA, pp. 112:4 A426, presented at Digestive Disease Week and the 98th Annual Meeting of the American Gastroenterological Association, Washington DC, USA, 11 May 1997 - 14 May 1997
    Conference Papers | 1997
    Apte MV; Norton ID; Haber PS; Applegate TL; Mccaughan GW; Korsten MA; Pirola RC; Wilson JS, 1997, 'Ethanol-induced increases in pancreatic enzyme content - a dietary artefact?', in Gastroenterology, W B Saunders Co, Philadelphia, PA, USA, pp. 112:4 A426, presented at Digestive Disease Week and the 98th Annual Meeting of the American Gastroenterological Association, Washington DC, USA, 11 May 1997 - 14 May 1997
    Conference Papers | 1997
    Haber PS; Norton ID; Apte MV; Applegate TL; Korsten MA; Pirola RC; Wilson JS, 1997, 'Identification of stellate cells in the rat pancreas', in Gastroenterology, pp. A446 - A446, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997WV41901777&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 1997
    Haber PS; Norton ID; Apte MV; Applegate TL; Korsten MA; Pirola RC; Wilson JS, 1997, 'Identification of stellate cells in the rat pancreas', in Gastroenterology, W B Saunders Co, Philadelphia, PA, USA, pp. 112:4 A446, presented at Digestive Disease Week and the 98th Annual Meeting of the American Gastroenterological Association, Washington DC, USA, 11 May 1997 - 14 May 1997
    Preprints |
    Koopsen J; Matthews G; Rockstroh JK; Applegate TL; Bhagani SR; Grebely J; Rauch A; Sacks-Davis R; Ingiliz P; Boesecke C; Rebers S; Feld J; Bruneau J; Martinello M; Hellard ME; Dore GJ; Schinkel J; van der Valk M; Study Group REACT, Hepatitis C Virus Transmission Dynamics in a Global Cohort of Men Who Have Sex with Men with Recently Acquired Infection, http://dx.doi.org/10.2139/ssrn.4125248
    Preprints |
    Martinello M; Yee J; Bartlett SR; Read P; Baker D; Post J; Finlayson R; Bloch M; Doyle J; Shaw D; Rowling D; Doong N; Jackson E; Hellard M; Petoumenos K; Lin L; Marks P; Applegate T; Dore GJ; Matthews GV, Moving Towards HCV Elimination Among People Living with HIV in Australia: Analysis of the CEASE Prospective Cohort Study, http://dx.doi.org/10.2139/ssrn.3269607
    Preprints |
    Nyein PP; Tillakeratne SJ; Phyu S; Myint Myint Y; Lwin MM; Htike KL; Aung MT; Applegate TL; Hanson J; Matthews G; Lin KS, Evaluation of Simplified HCV Diagnostics in HIV/HCV Co-Infected Patients in Myanmar (Simplified Monitoring Myanmar SM <sub>2</sub> Study), http://dx.doi.org/10.2139/ssrn.4257640